Identification of human brain tumour initiating cells (scientific article (publication date: 18 November 2004))

cites work (P2860)

Q36951488	"Destemming" cancer stem cells
Q43122736	"Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells
Q40149136	"The development tumor model" to study and monitor the entire progression of both primary and metastatic tumors
Q39346476	"miR miR on the wall, who's the most malignant medulloblastoma miR of them all?"
Q35575628	'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors
Q33279153	(A)symmetric stem cell replication and cancer
Q42328282	3D Porous Chitosan-Alginate Scaffolds Promote Proliferation and Enrichment of Cancer Stem-Like Cells
Q41744145	5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells
Q37334123	8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin
Q36036418	A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma.
Q37588073	A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.
Q40517887	A 3D graphene oxide microchip and a Au-enwrapped silica nanocomposite-based supersandwich cytosensor toward capture and analysis of circulating tumor cells
Q97644245	A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation
Q91152081	A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells
Q34534070	A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations.
Q34437862	A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment
Q37745533	A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity
Q35782988	A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells
Q93379325	A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma
Q88640305	A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells
Q39366720	A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients
Q35102261	A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas
Q48026865	A Large-Scale RNAi Screen Identifies SGK1 as a Key Survival Kinase for GBM Stem Cells
Q39875396	A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells
Q26744651	A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
Q61814604	A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer Agent
Q45966683	A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival.
Q90150446	A Ploidy Increase Promotes Sensitivity of Glioma Stem Cells to Aurora Kinases Inhibition
Q36917813	A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo
Q42113076	A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex
Q47884138	A brief review of single-cell transcriptomic technologies
Q39192764	A cancer stem cell model for studying brain metastases from primary lung cancer
Q37086063	A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer.
Q64123499	A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer
Q34132933	A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo
Q34346483	A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma
Q93240382	A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
Q38710800	A comparison inhibitory effects of cisplatin and MNPs-PEG-cisplatin on the adhesion capacity of bone metastatic breast cancer
Q38797345	A comprehensive profile of recurrent glioblastoma
Q42269157	A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.
Q35801362	A concise review on the current understanding of pancreatic cancer stem cells
Q38867604	A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
Q55463442	A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.
Q27312887	A drosophila model for EGFR-Ras and PI3K-dependent human glioma
Q36962901	A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
Q55457034	A glial blueprint for gliomagenesis.
Q38763337	A glycoproteomic approach to identify novel glycomarkers for cancer stem cells
Q37626395	A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells
Q27304385	A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1
Q27860831	A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Q39717521	A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha
Q39432781	A label-free cytosensor for the enhanced electrochemical detection of cancer cells using polydopamine-coated carbon nanotubes
Q37023137	A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes
Q89629160	A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells
Q40058197	A mesenchymal glioma stem cell profile is related to clinical outcome
Q39670048	A microRNA Link to Glioblastoma Heterogeneity
Q39168444	A minority subpopulation of CD133(+) /EGFRvIII(+) /EGFR(-) cells acquires stemness and contributes to gefitinib resistance.
Q34000666	A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells
Q92203034	A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures
Q34568957	A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesis
Q41484437	A mouse model of the most aggressive subgroup of human medulloblastoma
Q34132666	A multigene predictor of outcome in glioblastoma.
Q92151546	A multiple breast cancer stem cell model to predict recurrence of T1-3, N0 breast cancer
Q37559173	A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells
Q45774902	A new methodological sequence to expand and transdifferentiate human umbilical cord blood derived CD133+ cells into a cardiomyocyte-like phenotype
Q37269588	A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).
Q28395647	A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells
Q45103335	A novel 18F-labelled high affinity agent for PET imaging of the translocator protein
Q39047678	A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes
Q36544739	A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Q28817916	A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells
Q38313102	A novel aptamer-based competition strategy for ultrasensitive electrochemical detection of leukemia cells
Q38033458	A novel concept of identifying precancerous cells to enhance anti-cancer therapies
Q30426915	A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells
Q48312117	A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Q39485541	A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Q37256752	A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors
Q52147578	A novel stem cell culture model of recurrent glioblastoma.
Q37997092	A novel treatment for glioblastoma: integrin inhibition
Q34685158	A novel zebrafish xenotransplantation model for study of glioma stem cell invasion
Q33616598	A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children
Q36555525	A physical mechanism of cancer heterogeneity
Q34928908	A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors
Q48185664	A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin
Q37377284	A progenitor cell origin of myeloid malignancies
Q37334258	A quest for initiating cells of head and neck cancer and their treatment
Q34533003	A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells
Q36096420	A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells
Q61443124	A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations
Q37582286	A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal
Q79379978	A renal cell carcinoma with components of both chromophobe and papillary carcinoma
Q38004911	A review of the role of stem cells in the development and treatment of glioma.
Q37877407	A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer.
Q37406681	A role for the NG2 proteoglycan in glioma progression
Q55399318	A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids.
Q42180579	A simplified and modified procedure to culture brain glioma stem cells from clinical specimens
Q34480521	A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models
Q35133408	A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo
Q24657433	A stochastic model for cancer stem cell origin in metastatic colon cancer
Q49030496	A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Q33598907	A subpopulation of cancer stem cells identifies radiographic characteristics in glioblastoma
Q39032927	A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.
Q38964404	A systematic review and meta-analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?
Q49074134	A theory and a model to understand glioblastoma development both in the bulk and in the microinfiltrated brain parenchyma.
Q38935921	A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes
Q34733314	A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells
Q39262600	A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy
Q36312839	A tumour stem cell hypothesis for the origins of prostate cancer
Q35655551	A versatile mathematical work-flow to explore how Cancer Stem Cell fate influences tumor progression
Q35967192	A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma
Q47118535	ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
Q36866385	ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma
Q37269034	ABCG1 maintains high-grade glioma survival in vitro and in vivo.
Q46064581	ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma
Q37587219	ABCG2: the key to chemoresistance in cancer stem cells?
Q53867361	AC133 expression associated with poor prognosis in stage II colorectal cancer.
Q35815285	ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
Q39036241	ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC.
Q33939548	ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma
Q33662919	ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
Q44068972	ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype
Q24657877	ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Q34769665	ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis
Q48021840	ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients
Q92790740	ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer
Q35484686	APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis
Q37944935	ARTS-based anticancer therapy: taking aim at cancer stem cells
Q33634637	ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
Q36941509	ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation
Q35581773	ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells
Q26773907	Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
Q36089699	Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity
Q39444412	Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors
Q34484134	Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
Q33582684	Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
Q34838175	Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas
Q38260515	Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting
Q37461452	Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549
Q57296293	Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival
Q39001812	Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma
Q38161369	Aberrant signaling pathways in glioma.
Q45807888	Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma
Q35116818	Ablation of breast cancer stem cells with radiation
Q37347838	Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors
Q34519687	Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation
Q41135787	Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
Q53251689	Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells.
Q28080068	Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening
Q53352599	Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.
Q35554585	Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest
Q35053662	Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells
Q47106297	Acetylation and deacetylation in cancer stem-like cells.
Q34056677	Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
Q47852896	Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency
Q37002410	Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma
Q90442508	Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype
Q33779474	Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells
Q39866091	Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells
Q40440133	Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells
Q35781533	Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
Q36799036	Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
Q34081431	Activation of c-MET induces a stem-like phenotype in human prostate cancer
Q36062158	Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
Q33869598	Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma
Q36092560	Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Q41819679	Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1-6 cells
Q35663008	Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells.
Q33809987	Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters
Q27335770	Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells
Q36164458	Acute myeloid leukemia stem cells
Q33525192	Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates
Q64912959	Adaptive Changes of Glioblastoma Cells Following Exposure to Hypoxic (1% Oxygen) Tumour Microenvironment.
Q38725573	Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
Q39685938	Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells
Q47903791	Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.
Q38823179	Addressing intra-tumoral heterogeneity and therapy resistance
Q42317561	Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells
Q45871162	Adenoviruses 16 and CV23 efficiently transduce human low-passage brain tumor and cancer stem cells
Q38951345	Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells
Q36935399	Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner
Q84654667	Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load
Q36960481	Adult marrow-derived very small embryonic-like stem cells and tissue engineering
Q38125628	Adult neural stem cells from the subventricular zone: a review of the neurosphere assay.
Q37478955	Adult neural stem cells in the mammalian central nervous system
Q38204976	Adult neurogenesis and glial oncogenesis: when the process fails.
Q38322795	Advanced research on vasculogenic mimicry in cancer
Q38160932	Advanced technologies for studying circulating tumor cells at the protein level.
Q49592876	Advances in Radiotherapy for Glioblastoma.
Q42065140	Advances in cancer nanomedicine
Q30358150	Advances in diagnostic and treatment modalities for intracranial tumors.
Q38777058	Advances in the molecular genetics of gliomas - implications for classification and therapy
Q35029985	Advances in translational research in neuro-oncology
Q90655969	Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates
Q36336049	Aggressive invasion is observed in CD133(-)/A2B5(+) glioma-initiating cells
Q35660303	Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage
Q24645253	Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis
Q39680687	Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
Q39397828	Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines
Q24597245	Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling
Q59791057	Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis
Q53288101	Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.
Q24657355	Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer
Q35628364	All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation
Q90446030	All-trans retinoic acid therapy induces asymmetric division of glioma stem cells from the U87MG cell line
Q34132833	Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma
Q89949763	Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells
Q37610799	Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
Q89683056	Alternative Mechanisms of p53 Action During the Unfolded Protein Response
Q45373303	Alternative lengthening of telomeres in human glioma stem cells.
Q90310336	Alu retrotransposons modulate Nanog expression through dynamic changes in regional chromatin conformation via aryl hydrocarbon receptor
Q40100647	Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer
Q41528938	An Overview of Lipid Droplets in Cancer and Cancer Stem Cells
Q42621989	An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.
Q33576451	An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature
Q30432036	An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.
Q35034623	An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
Q36771879	An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation
Q35212577	An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.
Q33275167	An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma
Q55467648	An update on mouse brain tumor models in cancer drug discovery.
Q38944047	An update on the epigenetics of glioblastomas
Q37643205	Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.
Q36145048	Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells
Q33718376	Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks
Q29615607	Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Q35127284	Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
Q42198162	Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo
Q46641516	Anaplastic astrocytomas: biology and treatment
Q36000884	Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas
Q37504362	Angiogenesis as a therapeutic target in malignant gliomas
Q35103863	Angiogenesis-independent tumor growth mediated by stem-like cancer cells
Q40974703	Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma
Q30455596	Angiogenic inhibition in high-grade gliomas: past, present and future
Q50998090	Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.
Q33820347	Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
Q33586204	Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Q36861061	Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats
Q37537572	Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma
Q37290626	Anti-cancer Therapies in High Grade Gliomas
Q46098974	Anti-oxidative and cholinesterase inhibitory effects of leaf extracts and their isolated compounds from two closely related Croton species.
Q37666618	Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?
Q35116982	Antibody approaches to prepare clinically transplantable cells from human embryonic stem cells: identification of human embryonic stem cell surface markers by monoclonal antibodies
Q55333253	Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells.
Q48564522	Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
Q38408987	Apigenin Inhibits Cancer Stem Cell-Like Phenotypes in Human Glioblastoma Cells via Suppression of c-Met Signaling
Q53345637	Apoptosis: the suicide solution in cancer treatment and chemoprevention.
Q38232301	Application of iPS cell technology to cancer epigenome study: uncovering the mechanism of cell status conversion for drug resistance in tumor
Q30446483	Applications of Microfluidics in Stem Cell Biology
Q36965370	Applications of emerging molecular technologies in glioblastoma multiforme
Q37483966	Applications of neural and mesenchymal stem cells in the treatment of gliomas
Q37601425	Aptamer identification of brain tumor-initiating cells
Q47942947	Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.
Q26830307	Are hematopoietic stem cells involved in hepatocarcinogenesis?
Q55164226	Are ovarian cancer stem cells the target for innovative immunotherapy?
Q33702796	Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype
Q35650870	Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
Q101038662	Assessing the prognostic value of stemness-related genes in breast cancer patients
Q37140126	Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Q48577873	Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.
Q34692759	Association between tumorigenic potential and the fate of cancer cells in a syngeneic melanoma model
Q53702204	Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival.
Q48318541	Association of stem cell marker CD133 expression with dissemination of glioblastomas
Q46328958	Association of stem cell-related markers and survival in astrocytic gliomas
Q34563444	Astrocytes enhance the invasion potential of glioblastoma stem-like cells
Q27490746	Astrocytes: biology and pathology
Q28292920	Asymmetric cell division of stem and progenitor cells during homeostasis and cancer
Q38731561	At the Crossroads of Cancer Stem Cells, Radiation Biology, and Radiation Oncology
Q59063751	At the root of brain cancer
Q57174294	Author Correction: Genetically engineered cerebral organoids model brain tumor formation
Q35631598	Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells
Q48649561	Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
Q42199873	Autophagy Induction by Endothelial-Monocyte Activating Polypeptide II Contributes to the Inhibition of Malignant Biological Behaviors by the Combination of EMAP II with Rapamycin in Human Glioblastoma
Q91387236	Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Q38462513	Autophagy and its function in radiosensitivity
Q33574520	B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells
Q37487279	BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells.
Q39674232	BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery
Q57805008	BMI1 is a therapeutic target in recurrent medulloblastoma
Q38352238	BMI1 sustains human glioblastoma multiforme stem cell renewal
Q33554078	BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells
Q92835238	BMP4 induces asymmetric cell division in human glioma stem-like cells
Q57482782	BORIS: a key regulator of cancer stemness
Q41855478	Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas
Q36213117	Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.
Q28279788	Beyond tumorigenesis: cancer stem cells in metastasis
Q33802553	Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.
Q90733830	Bioactive lipids in cancer stem cells
Q36562573	Biological and clinical implications of cancer stem cells in primary brain tumors
Q37982802	Biological and clinical relevance of stem cells in pancreatic adenocarcinoma
Q38757074	Biological and clinical significance of cancer stem cell plasticity
Q38943910	Biological characteristics of CD133(+) cancer stem cells derived from human laryngeal carcinoma cell line.
Q37001978	Biological characteristics of side population cells in a self-established human ovarian cancer cell line
Q36160333	Biological rationale for the design of polymeric anti-cancer nanomedicines
Q37533625	Biology of angiogenesis and invasion in glioma
Q34203979	Biology, genetics and imaging of glial cell tumours
Q50049701	Biomarker discovery for renal cancer stem cells.
Q38354849	Biomarkers and signaling pathways of colorectal cancer stem cells
Q47719520	Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype
Q89765517	Biophysical Regulation of Cancer Stem/Initiating Cells: Implications for Disease Mechanisms and Translation
Q33349898	Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells
Q36106864	Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells
Q37736204	Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
Q98945949	Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma
Q34428753	Bmi1 in development and tumorigenesis of the central nervous system
Q34183356	Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model
Q51516469	Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Q34065462	Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics
Q37389176	Bone marrow-derived progenitor cells could modulate pancreatic cancer tumorigenesis via peritumoral microenvironment in a rat model
Q36259173	Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Q36977668	Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma
Q48180382	Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells
Q40199613	Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
Q40071648	Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.
Q48228839	Brain Tumor Stem Cells Remain in Play
Q42658690	Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.
Q33760569	Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors
Q37627436	Brain cancer propagating cells: biology, genetics and targeted therapies
Q37335643	Brain cancer stem cells display preferential sensitivity to Akt inhibition
Q37604204	Brain cancer stem cells.
Q42576930	Brain cancer stem cells: current status on glioblastoma multiforme
Q33755959	Brain metastasis-initiating cells: survival of the fittest
Q34463432	Brain neoplasms and coagulation-lessons from heterogeneity
Q43542440	Brain tumor detection and segmentation in a CRF (conditional random fields) framework with pixel-pairwise affinity and superpixel-level features
Q30572367	Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.
Q37093560	Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts
Q33512545	Brain tumor stem cells
Q80292094	Brain tumor stem cells
Q27003138	Brain tumor stem cells: Molecular characteristics and their impact on therapy
Q37783774	Brain tumor stem cells: The cancer stem cell hypothesis writ large
Q57135138	Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity
Q26829741	Brain tumor-targeted drug delivery strategies
Q36488721	Brain tumour stem cells
Q36909352	Brain tumour stem cells: possibilities of new therapeutic strategies
Q36740051	Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells
Q39190749	Brazilin inhibits growth and induces apoptosis in human glioblastoma cells.
Q35683537	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
Q80442448	Breast cancer clinical and translational research: analogies and implications for prostate cancer
Q29618061	Breast cancer metastasis: markers and models
Q37901429	Breast cancer stem cells and their role in resistance to endocrine therapy
Q36946326	Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Q34257303	Breast cancer stem cells: Multiple capacities in tumor metastasis
Q36955061	Breast cancer stem cells: implications for therapy of breast cancer.
Q37839530	Breast cancer stem cells: treatment resistance and therapeutic opportunities
Q34025696	Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction
Q34257738	Brevican knockdown reduces late-stage glioma tumor aggressiveness.
Q41661065	Bromopropane Compounds Increase the Stemness of Colorectal Cancer Cells.
Q24322809	BuGZ is required for Bub3 stability, Bub1 kinetochore function, and chromosome alignment
Q37670709	Building a framework for embryonic microenvironments and cancer stem cells.
Q38683858	CANCER STEM CELLS IN OSTEOSARCOMA
Q49786885	CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.
Q42014961	CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance
Q21562426	CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent
Q35666904	CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
Q90573244	CD133 Expression in Glioblastoma Multiforme: A Literature Review
Q92405714	CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
Q49119174	CD133 and BMI1 expressions and its prognostic role in primary glioblastoma.
Q39043127	CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620.
Q37269065	CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
Q21093306	CD133 antigen expression in ovarian cancer
Q38035206	CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
Q58614144	CD133 as a regulator of cancer metastasis through the cancer stem cells
Q37990005	CD133 as a target for colon cancer
Q55466879	CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
Q26827628	CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis
Q33546702	CD133 expression in chemo-resistant Ewing sarcoma cells
Q53330530	CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.
Q39384559	CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
Q50279494	CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
Q36615659	CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
Q24652007	CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Q39722394	CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.
Q36962860	CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
Q43191501	CD133 expression predicts for non-response to chemotherapy in colorectal cancer
Q36416575	CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study
Q43533886	CD133 expression: a potential prognostic marker for non-small cell lung cancers
Q49107073	CD133 identifies perivascular niches in grade II-IV astrocytomas.
Q39245279	CD133 induces tumour-initiating properties in HEK293 cells.
Q28473995	CD133 is a marker of bioenergetic stress in human glioma
Q53288458	CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation.
Q34438511	CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer
Q39212552	CD133 is essential for glioblastoma stem cell maintenance.
Q98165148	CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
Q39351454	CD133 negatively regulates tumorigenicity via AKT pathway in synovial sarcoma
Q35822133	CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis
Q39243687	CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope
Q39659254	CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
Q37798837	CD133(+) cells isolated from various sources and their role in future clinical perspectives
Q39682422	CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential
Q34370179	CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
Q36170883	CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells
Q40076996	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.
Q36172819	CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence
Q37732341	CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells
Q39702845	CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells
Q39813754	CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
Q36458822	CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain
Q55463554	CD133+ niches and single cells in glioblastoma have different phenotypes.
Q35569794	CD133+ renal progenitor cells contribute to tumor angiogenesis
Q33534016	CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors
Q28066353	CD133, Selectively Targeting the Root of Cancer
Q38922806	CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
Q33793473	CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells
Q36434843	CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy
Q24645322	CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
Q37025715	CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cells
Q34091227	CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer
Q39922525	CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
Q33974370	CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Q38056153	CD133: holy of grail of neuro-oncology or promiscuous red-herring?
Q24615405	CD133: to be or not to be, is this the real question?
Q37325197	CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor
Q40895291	CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population
Q91785257	CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2
Q41868074	CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion
Q59797731	CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis
Q38967844	CD271 is an imperfect marker for melanoma initiating cells.
Q81100931	CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
Q38915605	CD38 is a putative functional marker for side population cells in human nasopharyngeal carcinoma cell lines
Q36288270	CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models.
Q39040951	CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.
Q64262837	CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
Q36484503	CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
Q45406868	CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma
Q36707404	CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
Q34018947	CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway
Q37093556	CD44variant exon 9 plays an important role in colon cancer initiating cells
Q91605942	CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
Q38717895	CD47: a potential immunotherapy target for eliminating cancer cells
Q34518394	CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits
Q38803617	CD90 a potential cancer stem cell marker and a therapeutic target
Q36209001	CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays
Q47292629	CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells
Q27329081	CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells
Q35955263	CDC20 maintains tumor initiating cells
Q36943876	CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia
Q34334389	CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression
Q51695278	CRTC2 and PROM1 expression in non-small cell lung cancer: analysis by Western blot and immunohistochemistry.
Q37190326	CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment
Q33677057	CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
Q89805077	CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
Q38197709	CXCR4 as biomarker for radioresistant cancer stem cells
Q37686164	CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
Q37066443	CXCR4 mediates the proliferation of glioblastoma progenitor cells
Q34948206	Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma
Q24561405	Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47
Q95840247	Can gliomas provide insights into promoting synaptogenesis?
Q26752312	Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
Q95277485	Cancer Stem Cell Plasticity - A Deadly Deal
Q26740207	Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
Q48769325	Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Q52571378	Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment.
Q33722499	Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells
Q24628819	Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?
Q60938527	Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
Q26765342	Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies
Q91707651	Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options
Q58411684	Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance
Q26771238	Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma
Q36899854	Cancer Stem Cells and the Bone Marrow Microenvironment
Q55254109	Cancer Stem Cells are Regulated by STAT3 Signalling in Wilms Tumour.
Q39393146	Cancer Stem Cells in Hepatocellular Carcinoma.
Q41927361	Cancer Stem Cells under Hypoxia as a Chemoresistance Factor in Breast and Brain
Q37017121	Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
Q53040917	Cancer Stem Cells.
Q38126498	Cancer Stem Cells: A Moving Target
Q37441234	Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance
Q38829440	Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm
Q38808963	Cancer Stem Cells: Formidable Allies of Cancer
Q91907215	Cancer Stem Cells: From Historical Roots to a New Perspective
Q33999773	Cancer associated fibroblasts (CAFs) in tumor microenvironment
Q46575709	Cancer biology: summing up cancer stem cells.
Q35348043	Cancer epigenetics: linking basic biology to clinical medicine.
Q37010433	Cancer induction by restriction of oncogene expression to the stem cell compartment
Q42316211	Cancer initiating-cells are enriched in the CA9 positive fraction of primary cervix cancer xenografts
Q38091173	Cancer stem cell contribution to glioblastoma invasiveness
Q53140630	Cancer stem cell definitions and terminology: the devil is in the details.
Q38234251	Cancer stem cell detection and isolation
Q37592247	Cancer stem cell genomics: the quest for early markers of malignant progression
Q37960771	Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research.
Q38239661	Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape?
Q60934336	Cancer stem cell impact on clinical oncology
Q37192661	Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
Q38007856	Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes
Q42006656	Cancer stem cell markers in head and neck squamous cell carcinoma.
Q38650088	Cancer stem cell markers: premises and prospects.
Q28079045	Cancer stem cell metabolism: a potential target for cancer therapy
Q37158535	Cancer stem cell research: current situation and problems.
Q42735675	Cancer stem cell subsets and their relationships
Q42332008	Cancer stem cell surface markers on normal stem cells
Q42074681	Cancer stem cell targeting using the alpha-particle emitter, 213Bi: mathematical modeling and feasibility analysis
Q37920789	Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges
Q41868891	Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study
Q33391372	Cancer stem cell-directed therapies: recent data from the laboratory and clinic
Q38939481	Cancer stem cell-like phenotype and survival are coordinately regulated by Akt/FoxO/Bim pathway.
Q33779353	Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
Q39014576	Cancer stem cell-targeted therapeutics and delivery strategies
Q26773998	Cancer stem cell-vascular endothelial cell interactions in glioblastoma
Q33254002	Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma
Q37167951	Cancer stem cells and brain tumors
Q37004676	Cancer stem cells and brain tumors: uprooting the bad seeds.
Q37841186	Cancer stem cells and cancer therapy
Q34557441	Cancer stem cells and epithelial ovarian cancer
Q38924208	Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer
Q38007261	Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links
Q50072739	Cancer stem cells and evolving novel therapies: a paradigm shift.
Q37217237	Cancer stem cells and glioma
Q37114128	Cancer stem cells and human malignant melanoma
Q42491583	Cancer stem cells and microenvironment in prostate cancer progression
Q38702970	Cancer stem cells and personalized cancer nanomedicine.
Q27008368	Cancer stem cells and radioresistance
Q37453248	Cancer stem cells and radiotherapy.
Q51775290	Cancer stem cells and the cell cycle: targeting the drive behind breast cancer.
Q33614696	Cancer stem cells and their mechanism of chemo-radiation resistance
Q37988791	Cancer stem cells and their potential implications for the treatment of solid tumors
Q36698757	Cancer stem cells and their role in metastasis
Q36796375	Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies
Q38472322	Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
Q33738159	Cancer stem cells are enriched in the side population cells in a mouse model of glioma
Q26785497	Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
Q37288044	Cancer stem cells as a potential therapeutic target in thyroid carcinoma
Q35390334	Cancer stem cells as a target population for drug discovery
Q55122201	Cancer stem cells as key drivers of tumour progression.
Q37009796	Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies
Q38421310	Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers
Q42330818	Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function
Q36539244	Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall
Q37662331	Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media.
Q28081844	Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
Q37426166	Cancer stem cells in brain tumor biology
Q26992115	Cancer stem cells in brain tumors and their lineage hierarchy
Q90706027	Cancer stem cells in esophageal squamous cell cancer
Q35829972	Cancer stem cells in glioblastoma
Q37825821	Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting
Q37634973	Cancer stem cells in glioma: challenges and opportunities
Q35023906	Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy
Q38161332	Cancer stem cells in head and neck cancer
Q41944225	Cancer stem cells in head and neck cancer
Q37919424	Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications
Q33241381	Cancer stem cells in human gastrointestinal cancers
Q37709551	Cancer stem cells in lung cancer: Evidence and controversies.
Q37759750	Cancer stem cells in lung tumorigenesis
Q37133709	Cancer stem cells in multiple myeloma.
Q92193226	Cancer stem cells in neuroblastoma therapy resistance
Q37896083	Cancer stem cells in osteosarcoma: recent progress and perspective
Q38118769	Cancer stem cells in pediatric sarcomas
Q38713728	Cancer stem cells in prostate cancer
Q33349066	Cancer stem cells in solid tumors: elusive or illusive?
Q28293535	Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Q36318605	Cancer stem cells in the mammalian central nervous system
Q49557760	Cancer stem cells revisited.
Q34921599	Cancer stem cells, cancer cell plasticity and radiation therapy
Q37077230	Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.
Q26998068	Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma
Q38728744	Cancer stem cells, metabolism, and therapeutic significance
Q36764900	Cancer stem cells--an old idea that's new again: implications for the diagnosis and treatment of breast cancer
Q26823015	Cancer stem cells--important players in tumor therapy resistance
Q37079713	Cancer stem cells--old concepts, new insights.
Q27025165	Cancer stem cells--the current status of an old concept: literature review and clinical approaches
Q26766132	Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments
Q39202839	Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells
Q37796629	Cancer stem cells: a new framework for the design of tumor therapies.
Q33867131	Cancer stem cells: a novel paradigm for cancer prevention and treatment
Q36821443	Cancer stem cells: a review
Q34086837	Cancer stem cells: a stride towards cancer cure?
Q33569712	Cancer stem cells: a systems biology view of their role in prognosis and therapy
Q83213559	Cancer stem cells: an evolving concept
Q38268164	Cancer stem cells: are they responsible for treatment failure?
Q38211401	Cancer stem cells: biological functions and therapeutically targeting
Q37598736	Cancer stem cells: cell culture, markers, and targets for new therapies
Q37876126	Cancer stem cells: characteristics and their potential role for new therapeutic strategies
Q34462722	Cancer stem cells: controversies in multiple myeloma
Q35857599	Cancer stem cells: impact, heterogeneity, and uncertainty
Q37053174	Cancer stem cells: implications for the progression and treatment of metastatic disease.
Q36318587	Cancer stem cells: lessons from leukaemia
Q37353947	Cancer stem cells: lessons from melanoma
Q43727971	Cancer stem cells: moving past the controversy
Q37398584	Cancer stem cells: relevance to SCT
Q41216714	Cancer stem cells: repair gone awry?
Q38264074	Cancer stem cells: small subpopulation or evolving fraction?
Q34516701	Cancer stem cells: the final frontier for glioma virotherapy.
Q28259527	Cancer stem cells: the lessons from pre-cancerous stem cells
Q38243378	Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy
Q39323975	Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma
Q41956329	Cancer stem-like cells persist in established cell lines through autocrine activation of EGFR signaling
Q92035791	Cancer stem-like cells with hybrid epithelial/mesenchymal phenotype leading the collective invasion
Q35280672	Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs
Q33338039	Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model
Q36761134	Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status
Q55467683	Cancer vaccines: a novel strategy to sensitize malignant glioma to chemotherapy.
Q37967692	Cancer, stem cells and cancer stem cells: old ideas, new developments
Q37209758	Cancer, stem cells, and oncolytic viruses
Q41881214	Cancer-Associated Fibroblasts Enhance the Gland-Forming Capability of Prostate Cancer Stem Cells
Q39244131	Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells
Q44243124	Cancer-initiating cell marker-positive cells generate metastatic tumors that recapitulate the histology of the primary tumors
Q37299578	Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies
Q37895975	Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays
Q52757480	Cancer: Division hierarchy leads to cell heterogeneity.
Q59066412	Cancer: The root of the problem
Q48345345	Cancer: stem cells and brain tumours
Q40187423	Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis
Q38989618	Carbon ion beam is more effective to induce cell death in sphere-type A172 human glioblastoma cells compared with X-rays
Q37557801	Carbon nanotubes in hyperthermia therapy
Q47158074	Carnosol controls the human glioblastoma stemness features through the epithelial-mesenchymal transition modulation and the induction of cancer stem cell apoptosis.
Q35205600	Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway
Q37661508	Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention
Q36636347	Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression
Q39696393	Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
Q33907955	Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells
Q36544417	Cell context-dependent dual effects of EFEMP1 stabilizes subpopulation equilibrium in responding to changes of in vivo growth environment
Q38005023	Cell cycle activation and aneuploid neurons in Alzheimer's disease
Q36692971	Cell cycle and lineage progression of neural progenitors in the ventricular-subventricular zones of adult mice
Q36922545	Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines
Q54197365	Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.
Q34503221	Cell fate determination factor Dachshund reprograms breast cancer stem cell function
Q55456671	Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient.
Q37332217	Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas
Q37769327	Cell of origin of lung cancer.
Q36925556	Cell polarity in development and cancer.
Q38383345	Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery
Q36541937	Cell therapies for glioblastoma
Q42119234	Cell-based selection provides novel molecular probes for cancer stem cells
Q41959565	Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth
Q28080701	Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations
Q55461242	Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF).
Q35828103	Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance
Q37525522	Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells
Q91755702	Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer
Q38644474	Cervical cancer stem cells
Q41605016	Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Q37515982	Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma
Q91410839	Challenges to curing primary brain tumours
Q44748938	Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation
Q37435101	Chapter 3: acquisition of membrane polarity in epithelial tube formation patterns, signaling pathways, molecular mechanisms, and disease.
Q28546911	Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents
Q42030727	Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells.
Q37981219	Characteristic features of stem cells in glioblastomas: from cellular biology to genetics
Q38098887	Characteristics of glioma stem cells
Q51966805	Characterization and transformation potential of "Synthetic" astrocytes differentiated from murine embryonic stem cells.
Q24650846	Characterization of CD133+ parenchymal cells in the liver: histology and culture
Q47874491	Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma initiating cells.
Q37068556	Characterization of adult neural stem cells and their relation to brain tumors
Q42804376	Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
Q48272280	Characterization of brain cancer stem cells: a mathematical approach
Q52724801	Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors.
Q51581224	Characterization of cancer stem cells from different grades of human colorectal cancer.
Q34203737	Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker
Q38877579	Characterization of glioma stem-like cells from human glioblastomas.
Q39898745	Characterization of human embryonic stem cells with features of neoplastic progression.
Q36111589	Characterization of liposarcoma cell lines for preclinical and biological studies
Q39299986	Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model
Q38673687	Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes.
Q34593551	Characterization of side population cells isolated from the gastric cancer cell line SGC-7901.
Q38715157	Characterization of stem-like cells in a new astroblastoma cell line
Q28301328	Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line
Q90543304	Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification
Q34043793	Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
Q48212220	Chemical genetics reveals a complex functional ground state of neural stem cells
Q35573448	Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
Q37351199	Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors
Q33908497	Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population
Q55396904	Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
Q35521316	Chemoresistance of glioblastoma cancer stem cells--much more complex than expected
Q47732905	Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line
Q52946367	Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-induced DNA damage.
Q65556507	Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
Q37799220	Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?
Q46926270	Chemotherapy resistance of glioblastoma stem cells
Q39323198	Chemotherapy sorting can be used to identify cancer stem cell populations
Q28085377	Chemotherapy targeting cancer stem cells
Q53516278	Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients.
Q37713662	Childhood medulloblastoma: current status of biology and treatment
Q81767654	Childhood solid tumours: a developmental disorder
Q64054786	Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner
Q39311213	Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity.
Q90051519	Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Q27004631	Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion
Q92859353	Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
Q64076920	Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC
Q36863260	Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells
Q38040618	Chromosomal translocations among the healthy human population: implications in oncogenesis
Q35128022	Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
Q36229244	Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells.
Q35133418	Cilengitide induces autophagy-mediated cell death in glioma cells
Q26778924	Circulating cancer stem cells: the importance to select
Q37315616	Circulating tumor cell enrichment based on physical properties.
Q90365564	Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme
Q34307782	Circulating tumor cells: from bench to bedside
Q35665706	Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.
Q89506916	Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma
Q38771008	Citation classics in neuro-oncology: assessment of historical trends and scientific progress
Q53471082	Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.
Q38954672	Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma
Q34357073	Clinical implications of cancer stem cell biology in hepatocellular carcinoma
Q33598382	Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation
Q30997872	Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.
Q35198499	Clinical review: The emerging cell biology of thyroid stem cells.
Q34221286	Clinical significance of Polycomb gene expression in brain tumors.
Q34037067	Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres.
Q46051896	Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma
Q54616742	Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
Q35132045	Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
Q33574875	Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma
Q48887298	Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue.
Q38775522	Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy
Q38591389	Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment
Q35102275	Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
Q24644883	Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance
Q38888052	Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro
Q39104687	Co-expression of CD44+/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma
Q55059317	Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
Q34321219	Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer
Q36358574	Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization
Q35573268	Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Q41860950	Colon Cancer Stem Cells: Bench-to-Bedside-New Therapeutical Approaches in Clinical Oncology for Disease Breakdown.
Q34176427	Colon cancer stem cells.
Q37825224	Colon cancer stem cells: implications in carcinogenesis
Q37220194	Colonic and colorectal cancer stem cells: progress in the search for putative biomarkers
Q34921375	Colorectal Cancer Stem Cells: Biology and Therapeutic Implications.
Q28391219	Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture
Q38161357	Colorectal cancer stem cells and cell death
Q45070615	Combating malignant astrocytes: Strategies mitigating tumor invasion.
Q64053377	Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells
Q51887600	Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Q41584450	Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment
Q57456667	Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Q42335701	Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation
Q54383762	Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity.
Q54977613	Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.
Q47096734	Combinatorial effects of an epigenetic inhibitor and ionizing radiation contribute to targeted elimination of pancreatic cancer stem cell
Q45065453	Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms
Q33720256	Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
Q34654670	Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma
Q54977810	Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma.
Q34549708	Common astrocytic programs during brain development, injury and cancer
Q38712948	Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma
Q38842832	Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells
Q36618220	Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors
Q39128660	Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target
Q39670555	Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines
Q36280796	Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies
Q35560334	Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway
Q93022866	Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments
Q34063075	Computational analysis of expression of human embryonic stem cell-associated signatures in tumors.
Q36303247	Computational analysis of the mesenchymal signature landscape in gliomas
Q55004259	Computational identification of specific genes for glioblastoma stem-like cells identity.
Q36388394	Concise review: Cancer stem cells and minimal residual disease
Q38180656	Concise review: Defining and targeting myeloma stem cell-like cells
Q35971159	Concise review: Emerging concepts in clinical targeting of cancer stem cells
Q34347602	Concise review: a high-content screening approach to stem cell research and drug discovery
Q35542866	Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram
Q38170363	Concise review: identifying limbal stem cells: classical concepts and new challenges.
Q38063851	Concise review: self-renewal in the central nervous system: neural stem cells from embryo to adult.
Q38120218	Concise review: the yin and yang of intestinal (cancer) stem cells and their progenitors
Q33691179	Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells
Q37479366	Conjunctival melanomas: can the cancer stem cell hypothesis be applied?
Q42653228	Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells
Q27026937	Contemporary murine models in preclinical astrocytoma drug development
Q37870808	Contribution of cancer stem cells to tumor vasculogenic mimicry
Q36201775	Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells
Q28251767	Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone
Q37174174	Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.
Q39028792	Control of glioma cell death and differentiation by PKM2-Oct4 interaction
Q38511670	Control of the blood-brain barrier function in cancer cell metastasis
Q37980722	Controlling the stem cell compartment and regeneration in vivo: the role of pluripotency pathways
Q39017301	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
Q36785112	Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling
Q37688839	Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
Q41253971	Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1.
Q36977690	Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.
Q48931499	Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
Q83402140	Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma
Q39459834	Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties
Q36678551	Cortical dysplasia: a possible substrate for brain tumors
Q26747513	Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?
Q41654291	Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.
Q37353493	Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer
Q39024553	Cripto-1 expression in glioblastoma multiforme
Q38066416	Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.
Q47122191	Crizotinib targets in glioblastoma stem cells.
Q38691508	Crossing the barrier: treatment of brain tumors using nanochain particles
Q38107895	Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?
Q39221235	Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Q37223775	Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells
Q37312531	Cryopreservation of neurospheres derived from human glioblastoma multiforme
Q36954190	Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression
Q39794629	Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Q42366669	Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?
Q36801277	Culturing in serum-free culture medium on collagen type-I-coated plate increases expression of CD133 and retains original phenotype of HT-29 cancer stem cell.
Q48124419	Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors
Q60046462	Current Options and Future Directions in Immune Therapy for Glioblastoma
Q41036239	Current Progresses of Single Cell DNA Sequencing in Breast Cancer Research
Q26865911	Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk
Q37777391	Current and emerging concepts in tumour metastasis
Q37809861	Current and emerging molecular targets in glioma
Q37904921	Current concepts and management of glioblastoma
Q37209811	Current status and issues in cancer stem cell study
Q33667686	Current status and perspectives of patient-derived xenograft models in cancer research
Q38169761	Current status of antiangiogenic therapies for glioblastomas
Q42183223	Current strategies for identification of glioma stem cells: adequate or unsatisfactory?
Q35864226	Current trends in targeted therapies for glioblastoma multiforme
Q36975824	Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells
Q28236409	Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma
Q90481871	Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches
Q38925756	Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors
Q37690293	Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis.
Q36472483	Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact
Q37061012	Cytoplasmic TRADD confers a worse prognosis in glioblastoma
Q39266662	Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
Q34773102	DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism
Q38858984	DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis
Q37636641	DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma
Q53662194	DNA methylation is a key factor in understanding differentiation phenotype in esophageal squamous cell carcinoma.
Q39847607	DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis
Q36328414	DNA micro-array analysis of myelodysplastic syndrome
Q28277249	De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures
Q42363804	Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity
Q36118290	Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing
Q42115145	Decoding the cancer stem cell hypothesis in glioblastoma
Q37677559	Deconstructing repression: evolving models of co-repressor action
Q39171562	Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes
Q28539951	Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase I
Q35144899	Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma
Q24298599	Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma
Q33966048	Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Q38739262	Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model
Q92289808	Deep sequencing and automated histochemistry of human tissue slice cultures improve their usability as preclinical model for cancer research
Q33747762	Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus
Q33591488	Defined factors induce reprogramming of gastrointestinal cancer cells
Q37328411	Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis
Q64076943	Definition of a multiple myeloma progenitor population in mice driven by enforced expression of XBP1s
Q42788716	Delayed cell death associated with mitotic catastrophe in γ-irradiated stem-like glioma cells
Q37308322	Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
Q90176783	Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes
Q36872033	Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation.
Q48483384	Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.
Q37392057	Dendritic-cell- and peptide-based vaccination strategies for glioma.
Q48267099	Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
Q38057886	Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.
Q36311161	Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma
Q35815783	Design and Characterization of Bioengineered Cancer-Like Stem Cells
Q47351335	Design and biological functionality of a novel hybrid Ti-6Al-4V/hydrogel system for reconstruction of bone defects.
Q33378520	Detection and characterization of CD133+ cancer stem cells in human solid tumours
Q34742636	Detection of CD133 (prominin-1) in a human hepatoblastoma cell line (HuH-6 clone 5).
Q30388310	Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody
Q35370135	Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
Q42563351	Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture
Q39346237	Detection of the cell viability and proliferation using two-signal electrochemical method
Q33796722	Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays
Q38727361	Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
Q39665034	Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells.
Q37896429	Development and maintenance of cancer stem cells under chronic inflammation
Q24546061	Development of NG2 neural progenitor cells requires Olig gene function
Q48539307	Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.
Q35788935	Development of a Sox2 reporter system modeling cellular heterogeneity in glioma
Q37164106	Development of a novel mouse glioma model using lentiviral vectors
Q34010866	Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar
Q26778787	Development of targeted therapies in treatment of glioblastoma
Q37000634	Developmental signaling pathways in brain tumor-derived stem-like cells.
Q39897131	Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population
Q48961381	Diagnosis of malignant glioma: role of neuropathology.
Q91896726	Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
Q37339931	Die hard: are cancer stem cells the Bruce Willises of tumor biology?
Q28546641	Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells
Q45787651	Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors.
Q92060916	Different Proteins Regulated Apoptosis, Proliferation and Metastasis of Lung Adenocarcinoma After Radiotherapy at Different Time
Q37119850	Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors
Q30657733	Differential connexin function enhances self-renewal in glioblastoma
Q39764373	Differential destruction of stem cells: implications for targeted cancer stem cell therapy
Q35214798	Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells
Q39120248	Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics
Q39186009	Differential effects of mesenchymal stem cells on a heterogeneous cell population within lung cancer cell lines
Q36684457	Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival
Q37716584	Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cel
Q34684614	Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.
Q83862831	Differential expression of neurofibromatosis 1 among discrete postnatal central nervous system progenitor populations
Q46033613	Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.
Q37622195	Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency
Q35544277	Differential remodeling of extracellular matrices by breast cancer initiating cells.
Q26782242	Differentiation and transdifferentiation potentials of cancer stem cells
Q35822393	Differentiation of Glioma Stem Cells and Progenitor Cells into Local Host Cell-Like Cells: A Study Based on Choroidcarcinoma Differentiation of Choroid Plexus of GFP Transgenic Nude Mouse
Q39024071	Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential
Q48377249	Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells
Q36931690	Diffuse glioma growth: a guerilla war
Q34035852	Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells
Q35176968	Direct reprogramming of stem cell properties in colon cancer cells by CD44
Q92327679	Discovering Rare Genes Contributing to Cancer Stemness and Invasive Potential by GBM Single-Cell Transcriptional Analysis
Q35748846	Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations
Q36916622	Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells.
Q35587229	Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas
Q37153084	Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
Q48025960	Dissecting human gliomas by single-cell RNA sequencing
Q21562662	Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers
Q38949124	Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients
Q34283082	Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.
Q39872681	Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution
Q37256791	Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma.
Q30429671	Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions
Q39263561	Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide
Q50089383	Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Q36038002	Diverging fates of cells of origin in acute and chronic leukaemia
Q36443392	Diverse roles for the paxillin family of proteins in cancer
Q39720409	Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency
Q39627253	Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells
Q37081022	Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
Q37687392	Do stem-like cells play a role in drug resistance of sarcomas?
Q36531871	Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial
Q35130100	Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells
Q38762579	Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells
Q34326145	Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways
Q36548751	Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis.
Q38850277	Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma
Q29619847	Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
Q34486691	Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
Q90103140	Drosophila melanogaster as a Model System for Human Glioblastomas
Q35566228	Drosophila melanogaster as a model system for human brain cancers
Q47169621	Drug Resistance Driven by Cancer Stem Cells and Their Niche
Q35899534	Drug resistance in glioblastoma: a mini review
Q38161343	Drug treatment of cancer cell lines: a way to select for cancer stem cells?
Q35424191	Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species
Q36957616	Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells
Q28473512	Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties
Q28477091	Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms
Q64065125	Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells
Q34480703	Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells
Q37325221	Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar Rhabdomyosarcoma
Q35910268	Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.
Q41812683	Dynamic modeling of genes controlling cancer stem cell proliferation
Q38902925	ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin
Q54487907	EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis.
Q26853549	EGFR Amplification and Glioblastoma Stem-Like Cells
Q90749189	EGFR blockade in GBM brain tumor stem cells synergizes with JAK2/STAT3 pathway inhibition to abrogate compensatory mechanisms in vitro and in vivo
Q28484249	EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential
Q34421001	EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
Q39677767	EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma
Q39314446	EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.
Q35091485	EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells
Q29616360	EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Q90168279	ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation
Q37392723	ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation
Q38712677	ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.
Q35603809	ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts
Q92408764	EZH2 Phosphorylation Promotes Self-Renewal of Glioma Stem-Like Cells Through NF-κB Methylation
Q37520284	EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling
Q35075212	EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner
Q35005020	Early human prostate adenocarcinomas harbor androgen-independent cancer cells
Q34509145	Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma
Q38997766	Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.
Q38404080	Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics
Q37297543	Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells
Q49384391	Editorial: The Role of Microenvironment in the Homing, Maintenance, and Release of Glioma Stem-Like Cells.
Q39379964	Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells.
Q38911461	Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma
Q34097753	Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells
Q35143965	Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion
Q30501156	Effect of doublecortin on self-renewal and differentiation in brain tumor stem cells
Q27309004	Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia
Q35867997	Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors
Q39655651	Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system
Q38301662	Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
Q48744925	Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers.
Q34457148	Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines
Q54336810	Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models.
Q36259647	Effects of recombinant erythropoietin on breast cancer-initiating cells
Q39953614	Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Q41833450	Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells.
Q39697091	Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
Q33786911	Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture
Q36635953	Efficient serum-free derivation of oligodendrocyte precursors from neural stem cell-enriched cultures
Q24648938	Efficient tumour formation by single human melanoma cells
Q90168524	Electrical and synaptic integration of glioma into neural circuits
Q52149321	Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis.
Q35943641	Elevated cell invasion in a tumor sphere culture of RSV-M mouse glioma cells
Q80534318	Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence
Q42704819	Elevated invasive potential of glioblastoma stem cells
Q34399678	Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells
Q34331960	Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling
Q36067817	Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop
Q50002280	Embedded Disposable Functionalized Electrochemical Biosensor with a 3D-Printed Flow Cell for Detection of Hepatic Oval Cells (HOCs).
Q37129279	Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
Q38155818	Embryonic stem cell-specific signature in cervical cancer.
Q28077156	Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
Q37439491	Emerging functions of microRNAs in glioblastoma
Q35914897	Emerging insights into the molecular and cellular basis of glioblastoma
Q26849477	Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach
Q55438519	Emerging role of lipid metabolism alterations in Cancer stem cells.
Q83903467	Emerging strategies for the identification and targeting of cancer stem cells
Q36502009	Emerging targets for glioblastoma stem cell therapy
Q34999744	Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells
Q37542578	Endocytosis, asymmetric cell division, stem cells and cancer: unus pro omnibus, omnes pro uno
Q48641867	Endogenous GABAA receptor activity suppresses glioma growth.
Q41781100	Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance.
Q55434339	Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p.
Q42174577	Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells
Q38843112	Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF.
Q34473290	Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties
Q33873312	Endothelium originated from colorectal cancer stem cells constitute cancer blood vessels
Q47390152	Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
Q38828829	Engineered T cells: the promise and challenges of cancer immunotherapy.
Q42077674	Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
Q90438838	Engineering cell heterogeneity into organs-on-a-chip
Q39381281	Engineering challenges for brain tumor immunotherapy
Q37603641	Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
Q35155160	Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastoma stem cell xenografts
Q39129183	Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions
Q39690598	Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells
Q35951834	Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation
Q37018003	Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs
Q36060236	Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells
Q37627644	Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation
Q38685020	Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
Q38898133	Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles
Q34541663	Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib
Q41960593	Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity
Q39137739	Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy
Q39144729	Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines
Q30493364	EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features
Q33993779	EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.
Q33926418	Epiblast/germ line hypothesis of cancer development revisited: lesson from the presence of Oct-4+ cells in adult tissues
Q34588662	Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells
Q42700778	Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance
Q38752590	Epidermal growth factor treatment of the adult brain subventricular zone leads to focal microglia/macrophage accumulation and angiogenesis.
Q37658825	Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
Q38708102	Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors
Q38213062	Epigenetic dysregulation in glioma.
Q37251747	Epigenetic gene regulation in stem cells and correlation to cancer
Q37366481	Epigenetic regulation in adult stem cells and cancers
Q34523621	Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
Q39932297	Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
Q38322068	Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
Q37179115	Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells
Q36138020	Epigenetic regulation of hematopoietic stem cell self-renewal by polycomb group genes.
Q36164492	Epigenetic regulation of normal and cancer stem cells
Q37961998	Epigenetic signatures in stem cells and cancer stem cells.
Q34135305	Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity
Q33715154	Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells
Q37618640	Epigenetics in cancer stem cells
Q33753468	Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma
Q47260956	Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview.
Q36992785	Epithelial ovarian cancer stem cells-a review
Q35230386	Epithelial-Mesenchymal Transition in tumor microenvironment
Q37621666	Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis
Q37721840	Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
Q38771479	Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.
Q32177990	Epithelial-mesenchymal transition and gastric cancer stem cell
Q37992229	Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype
Q31138688	Epithelial-mesenchymal transition associates with maintenance of stemness in spheroid-derived stem-like colon cancer cells
Q36986452	Epithelial-mesenchymal transition in breast cancer progression and metastasis
Q57109975	Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
Q33700204	Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer
Q33781308	Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence
Q88105265	Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges
Q34006181	Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance
Q37132697	Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence.
Q35974087	Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
Q39728608	Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Q47803240	Establishment of CMab-43, a Sensitive and Specific Anti-CD133 Monoclonal Antibody, for Immunohistochemistry.
Q37696049	Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique
Q40092976	Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization
Q38836198	Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells
Q36611096	Establishment of human iPSC-based models for the study and targeting of glioma initiating cells
Q42160676	Establishment of prognostic models for astrocytic and oligodendroglial brain tumors with standardized quantification of marker gene expression and clinical variables
Q46433342	Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations
Q33672901	Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients.
Q37463163	Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential
Q48572985	Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.
Q34160649	Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas
Q42025395	Evaluation of cancer stem cell migration using compartmentalizing microfluidic devices and live cell imaging
Q34569444	Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures
Q46117938	Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells
Q34132099	Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas
Q50482018	Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Q33815175	Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma
Q98733541	Evidence for hypoxia increasing the tempo of evolution in glioblastoma
Q34992194	Evidence for label-retaining tumour-initiating cells in human glioblastoma
Q33829820	Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy
Q28478709	Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma
Q40082305	Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death
Q37720671	Existence of a potential neurogenic system in the adult human brain.
Q40418868	Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
Q90589554	Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model
Q38543730	Existing drugs and their application in drug discovery targeting cancer stem cells.
Q57821810	Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis
Q42378449	Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells
Q33794878	Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
Q90099858	Experimental models and tools to tackle glioblastoma
Q48185318	Exploitation of adherent neural stem cells in basic and applied neurobiology.
Q36943380	Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets
Q39585488	Exploring the cancer stem cell phenotype with high-throughput screening applications
Q28282037	Exploring the role of cancer stem cells in radioresistance
Q36234890	Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors
Q53217376	Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
Q52355144	Expression and correlation of CD44 and GP73 in cerebroma tissues.
Q48246091	Expression and function of ABCG2 and XIAP in glioblastomas.
Q41130164	Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells.
Q89739841	Expression and prognostic role of E2F transcription factors in high-grade glioma
Q49986440	Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma.
Q44341014	Expression and prognostic value of JAM-A in gliomas.
Q37437973	Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
Q39477380	Expression and regulation of AC133 and CD133 in glioblastoma
Q28539708	Expression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-induced apoptosis
Q44048215	Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases
Q49494124	Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Q36291579	Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
Q47406752	Expression of CD133 as a Putative Prognostic Biomarker to Predict Intracranial Dissemination of Primary Spinal Cord Astrocytoma
Q39312637	Expression of CD133 in SW620 colorectal cancer cells is modulated by the microenvironment
Q37468314	Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
Q39633080	Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells
Q39495733	Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Q36954527	Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis
Q48381592	Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy
Q33596189	Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas
Q37300959	Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women
Q36845043	Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
Q42801189	Expression of dedifferentiation markers and multilineage markers in U251 glioblastoma cells with silenced EGFR and FGFR genes
Q47200266	Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells
Q79719099	Expression of immature and mature retinal cell markers in retinoblastoma
Q39969949	Expression of multidrug resistance genes in normal and cancer stem cells
Q24656542	Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model
Q48115550	Expression of stem cell markers in human astrocytomas of different WHO grades
Q35809608	Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease
Q33318981	Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
Q55463892	Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Q34440409	Expression patterns of Thymosin β4 and cancer stem cell marker CD133 in ovarian cancers
Q34331551	Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
Q37720504	Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma
Q39384371	Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer
Q21092375	Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen
Q34514940	Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy
Q42566287	Extinction models for cancer stem cell therapy
Q92444223	Extracellular Vesicle-Mediated Communication between the Glioblastoma and Its Microenvironment
Q33876259	Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma
Q38777383	Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors
Q90750956	Extracellular Vesicles as Conduits of Non-Coding RNA Emission and Intercellular Transfer in Brain Tumors
Q38781015	Extracellular Vesicles in Brain Tumor Progression
Q89621221	Extracellular Vesicles in Glioblastoma Tumor Microenvironment
Q35924477	Extracellular membrane vesicles and immune regulation in the brain
Q34797919	Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival
Q47148289	Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.
Q52667943	FACS-based Isolation of Neural and Glioma Stem Cell Populations from Fresh Human Tissues Utilizing EGF Ligand.
Q38039165	FAK and Nanog cross talk with p53 in cancer stem cells
Q43757557	FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report
Q55096590	FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
Q34542012	FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells
Q61118475	FGL2 promotes tumor progression in the CNS by suppressing CD103 dendritic cell differentiation
Q37684595	FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
Q37709313	FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma
Q64075384	Facets of Communication: Gap Junction Ultrastructure and Function in Cancer Stem Cells and Tumor Cells
Q48134470	Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.
Q39055315	Fatty acid binding protein 7 as a marker of glioma stem cells.
Q28552301	Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
Q37566991	Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells
Q37881690	Finding the root of the problem: the quest to identify melanoma stem cells
Q36637643	First among equals: the cancer cell hierarchy
Q41694222	Flexible ligated ruthenium(II) self-assemblies sensitizes glioma tumor initiating cells in vitro
Q39095029	Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines
Q33367177	Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype
Q42875098	Flow cytometric determination of stem/progenitor content in epithelial tissues: an example from nonsmall lung cancer and normal lung
Q53449416	Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver.
Q46087519	Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy
Q37981990	Flow cytometry in cancer stem cell analysis and separation
Q36117190	Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin.
Q36700252	Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization
Q33789414	Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis
Q92509167	Folate can promote the methionine-dependent reprogramming of glioblastoma cells towards pluripotency
Q37511104	Folate receptor-targeting gold nanoclusters as fluorescence enzyme mimetic nanoprobes for tumor molecular colocalization diagnosis
Q36334761	Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line
Q39165033	FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells
Q35800767	FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Q39146574	Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells.
Q50351390	From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.
Q37157385	From the Cover: Neutralization of terminal differentiation in gliomagenesis
Q47446760	From tumor size and HER2 status to systems oncology for very early breast cancer treatment
Q37002179	From viruses to cancer stem cells: dissecting the pathways to malignancy
Q38889830	Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes
Q90589822	Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells
Q48363759	Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
Q39600283	Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells
Q36327392	Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis
Q39450226	Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination
Q55011366	Functional invadopodia formed in glioblastoma stem cells are important regulators of tumor angiogenesis.
Q37281605	Functional role of CLIC1 ion channel in glioblastoma-derived stem/progenitor cells
Q35444381	Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model
Q52632620	Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy.
Q26853233	G Protein-Coupled Receptor Signaling in Stem Cells and Cancer
Q37524887	G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells
Q41009856	G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells
Q47427460	GBM secretome induces transient transformation of human neural precursor cells
Q36122372	GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma
Q38966867	GFP stable transfection facilitated the characterization of lung cancer stem cells
Q27003270	GPCRs in stem cell function
Q39254893	GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth
Q48116809	GPR133 Promotes Glioblastoma Growth in Hypoxia.
Q112305456	GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death
Q28476300	GSK3beta regulates differentiation and growth arrest in glioblastoma
Q33391513	Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor
Q39682379	Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population.
Q39511329	Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells
Q92642770	Gap Junction Intercellular Communication in the Carcinogenesis Hallmarks: Is This a Phenomenon or Epiphenomenon?
Q27002840	Gastric cancer stem cells: a novel therapeutic target
Q35795934	Gastric cancer stem cells: evidence, potential markers, and clinical implications
Q37897490	Gastrointestinal stem cells in self-renewal and cancer
Q39182946	Gene analysis and dynamics of tumor stem cells in human glioblastoma cells after radiation
Q35440212	Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis
Q35069587	Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model
Q41894790	Gene expression of growth signaling pathways is up-regulated in CD133-positive medulloblastoma cells
Q33307000	Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells
Q39323688	Gene expression profiling of cancer stem cells in the Du145 prostate cancer cell line
Q36739411	Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.
Q35498674	Gene regulatory networks in embryonic stem cells and brain development
Q35118933	Gene therapy and targeted toxins for glioma
Q29619717	Generation of breast cancer stem cells through epithelial-mesenchymal transition
Q33704814	Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation.
Q57048305	Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Q37164504	Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions
Q90749611	Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model
Q37453787	Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Q34863513	Genetic and epigenetic analysis of putative breast cancer stem cell models.
Q34070508	Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas
Q48112393	Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability.
Q37838362	Genetic modeling of gliomas in mice: new tools to tackle old problems
Q47142772	Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.
Q57174300	Genetically engineered cerebral organoids model brain tumor formation
Q33855041	Genome and transcriptome profiles of CD133-positive colorectal cancer cells.
Q36850429	Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A
Q34257360	Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.
Q38330237	Genomic discoveries in adult astrocytoma
Q27015775	Genomic profiling in triple-negative breast cancer
Q39362601	Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma
Q48824831	Girdin maintains the stemness of glioblastoma stem cells.
Q33327359	Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma
Q48489790	Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.
Q38721207	Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression
Q26823823	Glioblastoma Circulating Cells: Reality, Trap or Illusion?
Q37284738	Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin System
Q37602543	Glioblastoma Multiforme Oncogenomics and Signaling Pathways
Q90271402	Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways
Q26765869	Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
Q38816630	Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest
Q50076163	Glioblastoma Stem Cells and Their Microenvironment.
Q26776219	Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
Q37807263	Glioblastoma Stem Cells: A Neuropathologist's View
Q89893288	Glioblastoma Stem Cells: Driving Resilience through Chaos
Q64056689	Glioblastoma Stem- Cells, Metabolic Strategy to Kill a Challenging Target
Q28079663	Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
Q90926971	Glioblastoma Therapy in the Age of Molecular Medicine
Q47097367	Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.
Q37973261	Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation
Q38516823	Glioblastoma antigen discovery--foundations for immunotherapy.
Q26859782	Glioblastoma cancer stem cells: Biomarker and therapeutic advances
Q35719080	Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment
Q38697178	Glioblastoma entities express subtle differences in molecular composition and response to treatment
Q21091187	Glioblastoma formation from cell population depleted of Prominin1-expressing cells
Q37021808	Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo
Q37415954	Glioblastoma multiforme therapy and mechanisms of resistance.
Q37287987	Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
Q38225874	Glioblastoma multiforme: State of the art and future therapeutics
Q38182805	Glioblastoma multiforme: a look inside its heterogeneous nature
Q37856463	Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models
Q37027203	Glioblastoma multiforme: the role of DSB repair between genotype and phenotype
Q35210792	Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness
Q37831190	Glioblastoma stem cells
Q35794896	Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.
Q38355702	Glioblastoma stem cells and stem cell-targeting immunotherapies.
Q37433709	Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche
Q38637150	Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression
Q39975456	Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.
Q38207605	Glioblastoma stem cells: Molecular characteristics and therapeutic implications
Q92500797	Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Q34151507	Glioblastoma stem-like cells give rise to tumour endothelium.
Q37907078	Glioblastoma stem-like cells-biology and therapeutic implications
Q38287518	Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.
Q61805771	Glioblastoma's Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research
Q38065976	Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies
Q37807468	Glioblastoma, cancer stem cells and hypoxia
Q40044872	Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
Q48419110	Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.
Q40448344	Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival.
Q38160735	Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment
Q36796616	Glioblastoma: Defining Tumor Niches
Q38393328	Glioblastoma: molecular pathways, stem cells and therapeutic targets
Q37491359	Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.
Q55463881	Glioblastomas: gliomagenesis, genetics, angiogenesis, and microenvironment
Q55457144	Glioma Cell and Astrocyte Co-cultures As a Model to Study Tumor-Tissue Interactions: A Review of Methods.
Q36015831	Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype
Q47867713	Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar
Q92760077	Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling
Q26765758	Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
Q37228242	Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling
Q35988225	Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.
Q42578340	Glioma and glioblastoma - how much do we (not) know?
Q33671783	Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy
Q37205122	Glioma formation, cancer stem cells, and akt signaling
Q27333552	Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV
Q36707721	Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1.
Q47932798	Glioma spheroids obtained via ultrasonic aspiration are viable and express stem cell markers: a new tissue resource for glioma research
Q39842716	Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens
Q37452665	Glioma stem cell research for the development of immunotherapy
Q37752381	Glioma stem cell signaling: therapeutic opportunities and challenges
Q34504805	Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma
Q36898699	Glioma stem cells and immunotherapy for the treatment of malignant gliomas
Q33378368	Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Q37782288	Glioma stem cells as a target for treatment
Q55463214	Glioma stem cells give rise to tumor endothelium: de novo vasculogenesis?
Q27860541	Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Q41055983	Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Q38244345	Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin
Q48673283	Glioma stem cells: not all created equal.
Q55462193	Glioma stem cells: their role in chemoresistance.
Q38202702	Glioma stem cells: turpis omen in nomen? (The evil in the name?).
Q90387793	Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation
Q33999299	Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.
Q100454881	Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
Q30275189	Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Q37832994	Glioma-initiating cells and molecular pathology: implications for therapy
Q99557261	Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy
Q35842160	Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein
Q34310698	Gliomagenesis and the use of neural stem cells in brain tumor treatment
Q60950196	Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature
Q40663520	Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo
Q40464373	Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation.
Q37615467	Global expression profile of tumor stem-like cells isolated from MMQ rat prolactinoma cell
Q37106907	Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation
Q36931101	Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity
Q34474236	Glycoproteomic analysis of glioblastoma stem cell differentiation
Q33840263	Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule
Q39583218	Growth factor receptors define cancer hierarchies
Q39274573	Growth factors from tumor microenvironment possibly promote the proliferation of glioblastoma-derived stem-like cells in vitro.
Q37744868	H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
Q35757997	HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity
Q35085958	HIF induces human embryonic stem cell markers in cancer cells.
Q37706009	HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway
Q35687115	HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
Q92604874	HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells
Q42056659	HIF-miR-215-KDM1B promotes glioma-initiating cell adaptation to hypoxia
Q33709584	HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia
Q37536623	HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy
Q37536896	HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells
Q33760690	HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells
Q41930875	HPV-E6 protein enriches the CD55(+) population in cervical cancer cells promoting radio-resistance and cancer aggressiveness
Q90692688	HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)
Q38984604	Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles--a role of the endocytic-exocytic pathway
Q34498952	Harnessing preclinical mouse models to inform human clinical cancer trials.
Q26801037	Harnessing the apoptotic programs in cancer stem-like cells
Q37654799	Harvey Cushing's attempt at the first human pituitary transplantation
Q33827450	Head and neck cancer stem cells: the side population
Q35952617	Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines
Q37892575	Heat shock protein-peptide complex in the treatment of glioblastoma.
Q42474956	Hedgehog controls neural stem cells through p53-independent regulation of Nanog
Q36667536	Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy
Q44007768	Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas
Q38979664	Hedgehog signaling sensitizes glioma stem cells to endogenous nano-irradiation.
Q34693946	Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Q54648645	Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells.
Q37821305	Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.
Q33626806	Hepatitis B virus infection and intrahepatic cholangiocarcinoma
Q59057885	Here, there, everywhere?
Q37137010	Hereditary diffuse gastric cancer and lost cell polarity: a short path to cancer
Q24625571	Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics
Q26851734	Heterogeneity and targeting of pancreatic cancer stem cells
Q92934298	Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
Q35050894	Heterogeneity maintenance in glioblastoma: a social network
Q36165598	Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
Q35050347	Heterogeneity of functional properties of Clone 66 murine breast cancer cells expressing various stem cell phenotypes
Q35670756	Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
Q50798445	Heterogeneous phenotype of human glioblastoma: in vitro study.
Q39475757	Hexokinase II in CD133+ and CD133- hepatoma BEL-7402 Cells
Q39014465	Hide-and-seek: the interplay between cancer stem cells and the immune system
Q55346143	High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
Q64941559	High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Q37745955	High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells
Q37589153	High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer
Q39953729	High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Q48334668	High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Q34977386	High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma
Q37450669	High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation
Q33281842	High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells: high expression of CD55 as a novel character for side-population
Q91789555	High-Risk Human Papillomavirus E7 Maintains Stemness Via APH1B In Cervical Cancer Stem-Cell Like Cells
Q93087327	High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Q37507256	High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor
Q24645020	Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
Q37469883	Highly Effective Auger-Electron Therapy in an Orthotopic Glioblastoma Xenograft Model using Convection-Enhanced Delivery
Q34789136	Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Q24656967	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Q38697884	Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation
Q35901357	Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma
Q35757248	Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma
Q50989231	Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
Q44640557	Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
Q92409868	Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
Q28484242	Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization
Q28476426	Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells
Q38950033	How stemlike are sphere cultures from long-term cancer cell lines? Lessons from mouse glioma models
Q34700749	Hox genes in hematopoiesis and leukemogenesis.
Q35664300	Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells
Q34052754	Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma
Q38665860	Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes
Q92811055	Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype
Q35906275	Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
Q35545282	Human cancer growth and therapy in immunodeficient mouse models
Q39514897	Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab.
Q35535809	Human cytomegalovirus gene expression in long-term infected glioma stem cells.
Q40115765	Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness
Q40514159	Human cytomegalovirus infection promotes the stemness of U251 glioma cells
Q39500714	Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
Q37447217	Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors
Q45344842	Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection
Q39182186	Human glioma-initiating cells show a distinct immature phenotype resembling but not identical to NG2 glia
Q35147451	Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
Q37626756	Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity
Q41897705	Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer
Q36540434	Human papillomavirus infections and cancer stem cells of tumors from the uterine cervix.
Q38024864	Human skin cancer stem cells: a tale of mice and men.
Q31068871	Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus
Q34607151	Humanized mice in translational biomedical research
Q35463653	Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling
Q38955907	Hypothermia stimulates glioma stem spheres to spontaneously dedifferentiate adjacent non-stem glioma cells
Q38036033	Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
Q44391299	Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells.
Q34087018	Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres
Q34438815	Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential
Q43283510	Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Q35549238	Hypoxia, stem cells and bone tumor
Q37221453	Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Q47337253	Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
Q33670820	Hypoxic tumor microenvironment and cancer cell differentiation
Q28550965	ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma
Q40430665	ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1 in Hodgkin's lymphoma
Q44536385	IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells
Q58111933	IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma
Q33276239	IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance
Q55463659	IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas.
Q24669531	IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Q52719932	IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma.
Q37687572	ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system
Q54977647	Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Q38921239	Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis
Q28545737	Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells
Q56544369	Identification and Quantification of Drug-Resistant Cells in Colorectal Tumor and Distal Margin
Q33559584	Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma
Q24609306	Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma
Q92383007	Identification and chemoresistance of cancer stem cells in HPV-negative oropharyngeal cancer
Q35958829	Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients
Q27860627	Identification and expansion of human colon-cancer-initiating cells
Q28259332	Identification and expansion of the tumorigenic lung cancer stem cell population
Q33921460	Identification and targeting of cancer stem cells
Q39630949	Identification of CD133(-)/telomerase(low) progenitor cells in glioblastoma-derived cancer stem cell lines
Q46792285	Identification of CD133+ cells in pituitary adenomas
Q33338468	Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor
Q41980889	Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma
Q61446577	Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells
Q39481277	Identification of CD44+CD24+ gastric cancer stem cells
Q89112546	Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro
Q36288237	Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.
Q24670758	Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma
Q30868592	Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms
Q38741186	Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens
Q37326086	Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes
Q59134257	Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma
Q38790973	Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
Q37718856	Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.
Q36293646	Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
Q34085302	Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas
Q39983699	Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells
Q35078367	Identification of a population of epidermal squamous cell carcinoma cells with enhanced potential for tumor formation
Q34137275	Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer
Q29620604	Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
Q39160914	Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stem-like cell properties by high aldehyde dehydrogenase activity
Q39692941	Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
Q39299229	Identification of cancer stem cells derived from a canine lung adenocarcinoma cell line
Q39474036	Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Q39889919	Identification of cancer stem cells in dog glioblastoma
Q38008952	Identification of cancer stem cells provides novel tumor models for drug discovery
Q33348343	Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods
Q33835228	Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach
Q24622896	Identification of cells initiating human melanomas
Q49234702	Identification of differentially expressed genes in oral squamous cell carcinoma TCA8113 cells.
Q45864365	Identification of diverse astrocyte populations and their malignant analogs.
Q89231936	Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma
Q35874854	Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray
Q34451382	Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.
Q33620053	Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells
Q40013131	Identification of local and circulating cancer stem cells in human liver cancer
Q24656933	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells
Q34965970	Identification of molecular signature of head and neck cancer stem-like cells
Q39983663	Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials
Q34415158	Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells
Q36271573	Identification of therapeutic targets for glioblastoma by network analysis
Q40204383	Identification of tumor-initiating cells derived from two canine rhabdomyosarcoma cell lines
Q37385991	Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.
Q28469143	Identification of uPAR-positive chemoresistant cells in small cell lung cancer
Q24657020	Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Q38332486	Identify multiple myeloma stem cells: Utopia?
Q37574383	Identifying and enumerating neural stem cells: application to aging and cancer
Q37181138	Identifying candidate genes involved in brain tumor formation
Q83695984	Identity, fate and potential of cells grown as neurospheres: species matters
Q39655929	Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells
Q38228652	Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles
Q36882972	Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
Q39509042	Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window
Q33536079	Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
Q37773254	Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells
Q38431469	Immunobiology and immunotherapeutic targeting of glioma stem cells
Q35984406	Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy.
Q33574853	Immunocompetent murine models for the study of glioblastoma immunotherapy
Q36303850	Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
Q48230920	Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium
Q42498935	Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma
Q55460423	Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome.
Q37159509	Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma
Q41475241	Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
Q34701587	Immunotherapy of brain cancers: the past, the present, and future directions
Q38212354	Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.
Q37891875	Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Q37971408	Immunotherapy targeting glioma stem cells--insights and perspectives
Q38588141	Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies
Q36213711	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Q42284347	Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
Q36799983	Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics
Q24306474	Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex
Q39360076	Implication of expression of Nanog in prostate cancer cells and their stem cells
Q50724690	Implication of tumor stem-like cells in the tumorigenesis of sporadic paraganglioma.
Q40327002	Implications of a simple mathematical model to cancer cell population dynamics
Q36677482	Implications of cancer stem cells in the treatment of cancer
Q38685276	Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment
Q30452219	Improving the radiosensitivity of radioresistant and hypoxic glioblastoma
Q37229285	In search of liver cancer stem cells.
Q27332126	In silico experimentation of glioma microenvironment development and anti-tumor therapy
Q36232533	In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas
Q39445496	In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
Q37071839	In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
Q41681466	In vitro anticancer drug test: A new method emerges from the model of glioma stem cells.
Q39195246	In vitro enrichment of tumor-initiating cells from human established cell lines
Q38316551	In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells
Q36645642	In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression
Q33380152	In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines
Q48591268	In vitro identification and functional characterization of glial precursor cells in human gliomas.
Q37720016	In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
Q28076101	In vitro models of cancer stem cells and clinical applications
Q35545752	In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells
Q36500035	In vitro stemness characterization of radio-resistant clones isolated from a medulloblastoma cell line ONS-76
Q36299611	In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
Q48731998	In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
Q37305741	In vivo imaging, tracking, and targeting of cancer stem cells
Q39929595	In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line
Q39499299	In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla
Q26820289	In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies
Q26828630	In vivo molecular imaging of cancer stem cells
Q45934795	Incidence of first primary central nervous system tumors in California, 2001-2005: children, adolescents and teens.
Q35440815	Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma
Q26798210	Increased Oxidative Stress as a Selective Anticancer Therapy
Q34756941	Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease
Q53339373	Increased expression of stem cell markers in malignant melanoma.
Q35653328	Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells
Q47216499	Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells
Q34534217	Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
Q46359225	Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex
Q38174336	Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy
Q35845241	Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma
Q43940962	Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
Q39520956	Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ.
Q23921936	Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes
Q38751001	Influence of nuclear structure on the formation of radiation-induced lethal lesions.
Q36939783	Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors
Q36764876	Inhibiting kinases in malignant gliomas
Q30353578	Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).
Q34231228	Inhibition of BET bromodomain targets genetically diverse glioblastoma
Q33756997	Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.
Q52727111	Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Q37632115	Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.
Q58728819	Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability
Q36891085	Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
Q36051827	Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells
Q41017478	Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma
Q104795254	Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model
Q92853154	Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming
Q54977044	Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.
Q33911184	Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature
Q43193981	Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells
Q50877858	Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.
Q38675876	Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma
Q37004664	Inhibition of angiogenesis and invasion in malignant gliomas
Q91684485	Inhibition of autophagy enhances the antitumour activity of tigecycline in multiple myeloma
Q58799521	Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
Q57299883	Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
Q28476019	Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8
Q28488474	Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer
Q38791887	Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells
Q34363706	Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
Q41164580	Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate
Q35757228	Inhibition of notch signaling induces neural differentiation in Ewing sarcoma
Q39411350	Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells
Q37368670	Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.
Q36802989	Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling
Q35440540	Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.
Q39030443	Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.
Q50649768	Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.
Q42066665	Innate neural stem cell heterogeneity determines the patterning of glioma formation in children
Q36740046	Insights into neural stem cell biology from flies.
Q37029570	Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts
Q34023186	Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells
Q34259262	Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme
Q36745073	Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties
Q92442093	Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma
Q33908472	Integrin alpha 6 regulates glioblastoma stem cells
Q33766299	Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer
Q36272371	Intensity-Curvature Measurement Approaches for the Diagnosis of Magnetic Resonance Imaging Brain Tumors
Q30525687	Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.
Q39399161	Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine.
Q38829967	Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
Q39397148	Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells.
Q39389439	Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro
Q38051761	Interleukins in glioblastoma pathophysiology: implications for therapy.
Q63722737	International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma
Q34687012	Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models.
Q37228622	Intra-operatively obtained human tissue: protocols and techniques for the study of neural stem cells
Q39139446	Intra-tumor heterogeneity from a cancer stem cell perspective.
Q26783055	Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Q30617352	Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas
Q89896209	Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
Q38838354	Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
Q61796209	Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion
Q47911139	Introduction to Cancer Stem Cells: Past, Present, and Future
Q39168665	Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures
Q28253680	Invasive growth: a MET-driven genetic programme for cancer and stem cells
Q48793295	Investigating a candidate cell of origin for diffuse intrinsic pontine glioma.
Q34755413	Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.
Q39593909	Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP
Q91714035	Investigation of miRNA and mRNA Co-expression Network in Ependymoma
Q90321120	Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype
Q46986339	Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells.
Q39267913	Involvement of histone demethylase LSD1 in short-time-scale gene expression changes during cell cycle progression in embryonic stem cells
Q35025350	Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells
Q36298544	Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy
Q38709497	Ionizing radiation augments glioma tropism of mesenchymal stem cells
Q36746959	Ionizing radiation in glioblastoma initiating cells.
Q34395869	Ionizing radiation induces stemness in cancer cells
Q42933366	Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions
Q64075548	Iron Metabolism in Liver Cancer Stem Cells
Q98289965	Irradiated mesenchymal stem cells support stemness maintenance of hepatocellular carcinoma stem cells through Wnt/β-catenin signaling pathway
Q33642194	Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma
Q36667281	Is CD133 a marker of metastatic colon cancer stem cells?
Q37805181	Is HCMV a tumor promoter?
Q37975925	Is human cytomegalovirus a target in cancer therapy?
Q38782085	Isolation and Characterization of Cancer Stem Cells of the Non-Small-Cell Lung Cancer (A549) Cell Line.
Q36026199	Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Q92541866	Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study
Q40081869	Isolation and characterisation of cancer stem cells from canine osteosarcoma
Q36592530	Isolation and characteristics of CD133‑/A2B5+ and CD133‑/A2B5‑ cells from the SHG139s cell line
Q34625269	Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma.
Q33227579	Isolation and characterization of human mammary stem cells.
Q33699749	Isolation and characterization of potential cancer stem cells from solid human tumors--potential applications
Q39525075	Isolation and characterization of spheroid cells from the HT29 colon cancer cell line
Q48092193	Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
Q38431429	Isolation and characterization of stem cells from human central nervous system malignancies
Q39429617	Isolation and characterization of stem-like cells from a human ovarian cancer cell line
Q82663858	Isolation and characterization of tumor stem-like cells from human meningiomas
Q39645896	Isolation and identification of cancer stem cells from a side population of a human hepatoblastoma cell line, HuH-6 clone-5.
Q39257858	Isolation and identification of cancer stem-like cells from side population of human prostate cancer cells
Q34788138	Isolation and in vitro culture of rare cancer stem cells from patient-derived xenografts of pancreatic ductal adenocarcinoma.
Q34213324	Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
Q48664790	Isolation of Glioma-Initiating Cells for Biological Study.
Q41824204	Isolation of cancer stem cells from human prostate cancer samples
Q45073630	Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens.
Q34410639	Isolation of side population cells in B-cell non-Hodgkin's lymphomas
Q53324484	Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen.
Q37287398	Isolation of tumour stem-like cells from benign tumours
Q35123782	Isolation, cultivation and identification of brain glioma stem cells by magnetic bead sorting
Q39055537	Isolation, identification, and characterization of cancer stem cells: A review
Q36129189	Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
Q52007642	Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.
Q36984826	KDM1 is a novel therapeutic target for the treatment of gliomas
Q37604367	KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness
Q26795737	Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells
Q46555496	Killing time for cancer cells
Q51804957	Kinetics of the formation of cancer metastases via induced premetastatic cancer-stem-cell niches.
Q40842765	Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells
Q39678731	Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cells
Q46879426	Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance
Q39466430	Knockdown of ubiquitin ligases in glioblastoma cancer stem cells leads to cell death and differentiation
Q35136175	Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
Q34939838	Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion
Q34087027	Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.
Q34552685	Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition
Q36452206	Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells
Q41962409	L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
Q91205097	LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma
Q48437685	LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells.
Q43641188	LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
Q39256587	LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution
Q95326098	LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2
Q36621286	Label-free quantitative proteomics of CD133-positive liver cancer stem cells
Q41855549	Label-retaining cells in the rat submandibular gland
Q38431444	Laboratory models for central nervous system tumor stem cell research
Q36737141	Laminin alpha 2 enables glioblastoma stem cell growth
Q38737023	Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line.
Q38875547	Large-scale assessment of the gliomasphere model system
Q36425752	Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma
Q47096861	Lentivirus-mediated RNA interference inhibits the tumorigenicity of cluster of differentiation 44+ tumor cells in hypopharyngeal cancer
Q38837893	Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer
Q35895174	Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.
Q37904866	Lessons from common markers of tumor-initiating cells in solid cancers
Q53302987	Leukaemia stem cells and the evolution of cancer-stem-cell research.
Q55387154	Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes.
Q37355972	Leukemia stem cells and human acute lymphoblastic leukemia.
Q39136332	Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures
Q58755619	Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
Q48246263	Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells
Q36995745	Limitations of the cancer stem cell theory
Q39180013	Lin28a is a putative factor in regulating cancer stem cell-like properties in side population cells of oral squamous cell carcinoma.
Q35211551	Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Q40087896	Linking differential radiation responses to glioma heterogeneity
Q37676222	Links between DNA Replication, Stem Cells and Cancer
Q27004529	Links between cancer stem cells and epithelial-mesenchymal transition
Q33747559	Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity
Q30851435	Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis
Q35958012	Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential
Q64951781	Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion.
Q38176848	LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.
Q34186515	Localization of CD44 and CD90 positive cells to the invasive front of breast tumors
Q36945388	Location, location, location: the cancer stem cell niche
Q44243239	Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.
Q54959875	Long Non-Coding RNAs Dysregulation and Function in Glioblastoma Stem Cells.
Q91741769	Long non-coding RNA GAS5 is critical for maintaining stemness and induces chemoresistance in cancer stem-like cells derived from HCT116
Q36020925	Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Q37693612	Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression
Q35879903	Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells
Q35792968	Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation
Q33413437	Loss of heterozygosity of TRIM3 in malignant gliomas
Q36813932	Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer
Q49029463	Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
Q39025769	Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death
Q28481463	Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation
Q33786637	Lung cancer stem cell: new insights on experimental models and preclinical data.
Q37763495	Lung cancer stem cells: tools and targets to fight lung cancer.
Q26824222	Lung cancer-initiating cells: a novel target for cancer therapy
Q34094849	Lung cancer: developmental networks gone awry?
Q91907224	Ly6G+ inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model
Q33632266	Lymphoma stem cells: enough evidence to support their existence?
Q39932965	M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma
Q35925281	MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties
Q37720052	MC3 Mucoepidermoid carcinoma cell line enriched cancer stem-like cells following chemotherapy
Q92257541	MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
Q37098261	MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
Q38760569	MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma
Q47739151	MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
Q45943224	MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
Q47821487	Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling.
Q27004205	Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy
Q54376413	Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
Q41472760	Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway
Q39739576	Maintenance of critical properties of brain tumor stem-like cells after cryopreservation.
Q38077437	Maintenance of genomic stability in mouse embryonic stem cells: relevance in aging and disease
Q35696355	Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Q51977217	Making a tumour's bed: glioblastoma stem cells and the vascular niche.
Q43170042	Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model
Q35788726	Malignant clinical features of anaplastic gliomas without IDH mutation
Q37998643	Malignant glioma: lessons from genomics, mouse models, and stem cells
Q36582393	Malignant glioma: neuropathology and neurobiology.
Q37812069	Malignant gliomas: new translational therapies.
Q26744387	Malignant gliomas: old and new systemic treatment approaches
Q33739686	Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells
Q33735595	Mammary development and breast cancer: the role of stem cells
Q36943351	Mammary stem cells and breast cancer--role of Notch signalling.
Q37476857	Management of newly diagnosed glioblastoma: guidelines development, value and application
Q92556562	Mapping theme trends and knowledge structures for human neural stem cells: a quantitative and co-word biclustering analysis for the 2013-2018 period
Q43806150	Marker-independent identification of glioma-initiating cells
Q36945952	Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma
Q51928625	Mathematical model for NF-kappaB-driven proliferation of adult neural stem cells.
Q28303953	Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis
Q28292878	Mathematical model for the cancer stem cell hypothesis
Q37581947	Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules
Q39168190	Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancer
Q34056327	Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation
Q37362644	Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
Q37145857	Mechanisms of Disease: cancer stem cells--targeting the evil twin
Q37180875	Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas
Q38828353	Mechanisms of tumor cell resistance to the current targeted-therapy agents.
Q64993228	Mechanobiology of Cancer Stem Cells and Their Niche.
Q41428961	Mediated coalescence: a possible mechanism for tumor cellular heterogeneity
Q36882529	Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells
Q37186416	Medulloblastoma stem cells
Q26750427	Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
Q37995022	Medulloblastoma stem cells: where development and cancer cross pathways.
Q39735898	Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.
Q28299667	Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
Q91826570	Medulloblastomics revisited: biological and clinical insights from thousands of patients
Q46968802	Meeting report: Barossa 2005--Signaling Networks
Q64226720	Meeting the Challenge of Targeting Cancer Stem Cells
Q36640682	Melanocytes, melanocyte stem cells, and melanoma stem cells
Q38224624	Melanoma epigenetics: novel mechanisms, markers, and medicines.
Q83737928	Melanoma stem cells: not rare, but well done
Q37360062	Melanoma-initiating cells: a compass needed.
Q39158092	Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.
Q57174410	Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
Q35875862	Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway
Q48025819	Mesenchymal Stem Cells as Natural Bio-Factories for Exosomes Carrying miR-124a in the Treatment of Gliomas
Q26770002	Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
Q55466441	Mesenchymal differentiation of glioblastoma stem cells.
Q36884210	Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Q37016591	Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal
Q40511505	Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Q33728678	Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival
Q40052794	Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice
Q97525205	Metabolic Adaptations in Cancer Stem Cells
Q38936264	Metabolic Features of Cancer Treatment Resistance
Q52659354	Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.
Q92721625	Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells
Q52731934	Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
Q50089305	Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
Q35008587	Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.
Q35229102	Metabolic state of glioma stem cells and nontumorigenic cells
Q64906270	Metabolic traits of cancer stem cells.
Q36560256	Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.
Q33591900	Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas
Q34639530	Metastasis: new perspectives on an old problem
Q26850739	Metastatic cancer stem cells: from the concept to therapeutics
Q30639268	Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Q37720793	Metastatic stem cells: sources, niches, and vital pathways
Q64083249	Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines
Q38555403	Metformin and prostate cancer stem cells: a novel therapeutic target
Q47852873	Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
Q36026661	Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis
Q34768858	Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?
Q61806914	Mi-2/NuRD complex protects stem cell progeny from mitogenic Notch signaling
Q37187706	MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells
Q27320938	MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma
Q38930784	MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein
Q33614641	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence
Q39203809	MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines
Q27002604	MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours
Q38770220	MicroRNA and extracellular vesicles in glioblastoma: small but powerful
Q28032481	MicroRNA expression profiles classify human cancers
Q55460933	MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Q64108747	MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer
Q37420580	MicroRNA in Human Glioma
Q34685896	MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons
Q37745975	MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Q39168771	MicroRNA-107 inhibits U87 glioma stem cells growth and invasion
Q36347204	MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme
Q41871901	MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells
Q41846503	MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma
Q39426030	MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways
Q37722172	MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer.
Q34579942	MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor
Q53174449	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Q27350129	MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma
Q35545762	MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.
Q39281229	MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell
Q39351996	MicroRNA-34a suppresses cell proliferation and induces apoptosis in U87 glioma stem cells
Q24603505	MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells
Q59789854	MicroRNA-451a overexpression induces accelerated neuronal differentiation of Ntera2/D1 cells and ablation affects neurogenesis in microRNA-451a-/- mice
Q35580808	MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.
Q37710925	MicroRNA-induced silencing of glioma progression.
Q37517191	MicroRNAs and glioblastoma; the stem cell connection
Q26828793	MicroRNAs are involved in the self-renewal and differentiation of cancer stem cells
Q37897499	MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme
Q38223219	MicroRNAs in cancer stem cells: current status and future directions
Q26865287	MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells
Q26747273	MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
Q28083277	MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown
Q33777662	MicroRNAs involved in neoplastic transformation of liver cancer stem cells
Q64230031	MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness
Q34348967	MicroRNAs, cancer and cancer stem cells
Q42127785	MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs
Q41059804	MicroRNA‑141 inhibits the self‑renewal of glioblastoma stem cells via Jagged1
Q28546959	Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells
Q34420086	Microenvironmental regulation of glioblastoma radioresponse
Q39266434	Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity
Q64238263	Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma
Q57460356	Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity
Q53219309	Migration of Transformed Bone Marrow-Derived Cells with Peripheral Neural Tumor Traits In Vivo.
Q37299267	Miscreant myeloproliferative disorder stem cells
Q35205681	Mitochondria as therapeutic targets for cancer stem cells
Q33761744	Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.
Q30300490	Mitochondrial control by DRP1 in brain tumor initiating cells
Q46449459	Modeling Physiologic Microenvironments in Three-Dimensional Microtumors Maintains Brain Tumor Initiating Cells
Q27333860	Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors
Q38827211	Modeling head and neck cancer stem cell-mediated tumorigenesis.
Q52011518	Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention.
Q39328610	Modeling the process of human tumorigenesis.
Q36717318	Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells
Q37610475	Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
Q39778278	Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
Q37001924	Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme.
Q94547415	Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells
Q90508484	Molecular Pathogenesis and Emerging Treatment for Glioblastoma
Q47563489	Molecular Pathogenesis of Radiation-Induced Cell Toxicity in Stem Cells.
Q91941998	Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion
Q33671442	Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
Q39786861	Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial.
Q92996626	Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
Q92626486	Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma
Q35192672	Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma
Q36478640	Molecular biology of human gliomas
Q26822406	Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers
Q36693476	Molecular characteristics of cancer stem-like cells derived from human breast cancer cells.
Q56891493	Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention
Q42518714	Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
Q38243193	Molecular heterogeneity of glioblastoma and its clinical relevance
Q35909465	Molecular imaging in tracking tumor stem-like cells
Q39148751	Molecular markers in glioma
Q37323726	Molecular mechanisms of hepatocellular carcinoma
Q38010801	Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
Q38756465	Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells
Q37925098	Molecular pathology of tumor-initiating cells: lessons from Philadelphia chromosome-positive leukemia
Q38156191	Molecular pathways and potential therapeutic targets in glioblastoma multiforme
Q36528894	Molecular pathways triggering glioma cell invasion
Q28307294	Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
Q38233134	Molecular prognostic factors in glioblastoma: state of the art and future challenges
Q37250253	Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Q90403191	Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities
Q33911283	Molecular targeting of glioblastoma: Drug discovery and therapies
Q36817109	Molecularly targeted therapies for malignant gliomas: advances and challenges
Q36829847	Molecularly targeted therapy for malignant glioma
Q47617131	Monoamines in Glioblastoma: complex biology with therapeutic potential.
Q28553543	Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway
Q64959961	Monoubiquitination of Cancer Stem Cell Marker CD133 at Lysine 848 Regulates Its Secretion and Promotes Cell Migration.
Q33661278	More than markers: biological significance of cancer stem cell-defining molecules
Q53262770	Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging.
Q35127020	Mosaic analysis with double markers reveals tumor cell of origin in glioma
Q30834482	Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness
Q39036703	Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells
Q41820623	Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.
Q33684472	Mouse models for cancer stem cell research
Q93585251	Mouse models for colorectal cancer
Q36547732	Mouse models of human non-small-cell lung cancer: raising the bar.
Q33945484	Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells
Q26701396	Multi-organ Mapping of Cancer Risk
Q38953085	Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?
Q94526791	Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
Q91627316	Multiple cancer pathways regulate telomere protection
Q37029171	Multiple myeloma cancer stem cells
Q37698645	Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis
Q30405446	Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma
Q35082670	Multiple tumor types may originate from bone marrow-derived cells
Q45869675	Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
Q34534660	Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis
Q40138545	Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements
Q36729321	Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential
Q36216894	Multispecies model of cell lineages and feedback control in solid tumors
Q50217013	Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
Q36299773	Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth
Q35112070	Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.
Q37111115	N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
Q64070787	NAMPT as a Dedifferentiation-Inducer Gene: NAD as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
Q90751684	NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
Q34085883	NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.
Q38256341	NANOG: a promising target for digestive malignant tumors
Q40201358	NDGA-P21, a novel derivative of nordihydroguaiaretic acid, inhibits glioma cell proliferation and stemness
Q37375751	NDRG4 is required for cell cycle progression and survival in glioblastoma cells
Q90309105	NEAT1 is Required for the Expression of the Liver Cancer Stem Cell Marker CD44
Q50027090	NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.
Q64983886	NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion.
Q39677226	NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl-N-nitrosourea-induced gliomagenesis
Q38941698	NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Q38842322	NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
Q33883897	NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts
Q38732520	NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma
Q39469827	NUMB does not impair growth and differentiation status of experimental gliomas
Q34679652	NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
Q36627192	Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition
Q47097576	Nanomedicine associated with photodynamic therapy for glioblastoma treatment
Q38794563	Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells
Q28079367	Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system
Q27011692	Nanomedicine therapeutic approaches to overcome cancer drug resistance
Q58695662	Nanotechnology for treatment of glioblastoma multiforme
Q42562347	Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies.
Q38675856	Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor
Q47845813	Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme
Q48242886	Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
Q39843692	Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
Q37268869	Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.
Q47296083	Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma
Q37980740	Neoplastic cells are a rare component in human glioblastoma microvasculature
Q36622723	Neoplastic stem cells: a novel therapeutic target in clinical oncology
Q37077666	Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Q38020421	Nestin and other putative cancer stem cell markers in pancreatic cancer
Q26851514	Nestin as a marker of cancer stem cells
Q43662312	Nestin expression identifies ependymoma patients with poor outcome
Q34521363	Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis
Q33559656	Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder
Q34452022	Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells.
Q93088940	Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications
Q37085039	Neural stem cells in the mammalian brain
Q38815922	Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma
Q35719811	Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
Q48222679	Neuroblastoma is composed of two super-enhancer-associated differentiation states.
Q45875651	Neuroblastoma pathogenesis: deregulation of embryonic neural crest development
Q50706561	Neurocytoma is a tumor of adult neuronal progenitor cells.
Q28265284	Neurofibromatosis type 1 - a model for nervous system tumour formation?
Q34305314	Neurofibromatosis type 1: modeling CNS dysfunction
Q36946598	Neuron-to-astrocyte transition: phenotypic fluidity and the formation of hybrid asterons in differentiating neurospheres
Q33452552	Neuronal aneuploidy in health and disease: a cytomic approach to understand the molecular individuality of neurons
Q38005043	Neuronal stem cells in the central nervous system and in human diseases
Q28729876	Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival
Q35210785	Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines
Q42427890	Neurosphere culture and human organotypic model to evaluate brain tumor stem cells.
Q35224959	Neurosphere formation is an independent predictor of clinical outcome in malignant glioma
Q38736387	Neurotrophin signaling in cancer stem cells
Q35055652	Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells
Q49182449	Neutralizing gp130 interferes with endothelial-mediated effects on glioblastoma stem-like cells.
Q50094787	New Opportunities and Challenges to Defeat Cancer Stem Cells.
Q38174477	New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs
Q34382914	New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence
Q37071188	New developments in medulloblastoma treatment: the potential of a cyclopamine-lovastatin combination
Q27026454	New insights in hepatocellular carcinoma: from bench to bedside
Q36674318	New insights into prostate cancer stem cells
Q37045475	New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133).
Q24680988	New molecularly targeted therapies for lung cancer
Q38187997	New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells
Q34003691	New promising drug targets in cancer- and metastasis-initiating cells
Q38154066	New treatment strategies to eradicate cancer stem cells and niches in glioblastoma
Q64951391	Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks.
Q58576103	Next-Generation Modeling of Human Cancers
Q90190658	Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma
Q48692740	Nomenclature of prominin-1 (CD133) splice variants - an update.
Q38189361	Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation
Q21562142	Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties
Q36121773	Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
Q39620283	Non-stem cell origin for oligodendroglioma
Q38885475	Noncoding RNAs in Cancer Cell Plasticity
Q37587716	Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells
Q39098613	Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells
Q28388647	Norcantharidin, derivative of cantharidin, for cancer stem cells
Q36228053	Normal and leukaemic stem cells
Q26825948	Normal and neoplastic urothelial stem cells: getting to the root of the problem
Q36712790	Normal breast stem cells, malignant breast stem cells, and the perinatal origin of breast cancer
Q37060259	Normal stem cells in cancer prone epithelial tissues.
Q90390334	Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and WNT
Q34373503	Not all side population cells contain cancer stem-like cells in human gastric cancer cell lines
Q49233427	Not just another biomarker: the role of integrin alpha 7 in glioblastoma.
Q24293345	Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells
Q39116742	Notch as a tumour suppressor.
Q30426621	Notch inhibitors as a new tool in the war on cancer: a pathway to watch
Q84921228	Notch promotes radioresistance of glioma stem cells
Q35626849	Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo
Q33826808	Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells
Q35622926	Notch signaling enhances nestin expression in gliomas
Q37785204	Notch signaling in solid tumors.
Q42371488	Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells.
Q37331040	Notch, neural stem cells, and brain tumors.
Q35164266	Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Q33829691	Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma.
Q39411406	Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1.
Q39377533	Notch: an interactive player in neurogenesis and disease
Q35981799	Notch: from neural development to neurological disorders
Q38324552	Notching on Cancer's Door: Notch Signaling in Brain Tumors
Q26777988	Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2
Q38728613	Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
Q37826349	Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors
Q30413140	Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.
Q21245491	Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
Q36873852	Novel association between microglia and stem cells in human gliomas: A contributor to tumour proliferation?
Q27006099	Novel delivery strategies for glioblastoma
Q37688017	Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
Q35587244	Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties
Q90382577	Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword
Q28750147	Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types
Q33994268	Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells
Q37198168	Novel strategies targeting cancer stem cells through phytochemicals and their analogs
Q34382586	Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies
Q93369543	Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells
Q37533630	Novel treatment strategies for malignant gliomas using neural stem cells.
Q64280118	Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
Q36186324	Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).
Q55456836	Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
Q35125899	Nucleostemin expression in invasive breast cancer
Q59137750	Numb Isoforms Deregulation in Medulloblastoma and Role of p66 Isoform in Cancer and Neural Stem Cells
Q28506397	Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors
Q59792014	Nutritional stress reprograms dedifferention in glioblastoma multiforme driven by PTEN/Wnt/Hedgehog axis: a stochastic model of cancer stem cells
Q36096925	O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions
Q38745576	ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
Q98513578	OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation
Q38833100	OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells
Q35118177	OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy
Q48883983	Oct-3/4 promotes migration and invasion of glioblastoma cells.
Q48473854	Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma.
Q28473082	Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells
Q54658264	Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway
Q92622543	Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme
Q28287898	Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma
Q55285476	Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border.
Q89631303	Oligodendrocyte Progenitor Cells in the Tumor Microenvironment
Q44414430	Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma
Q37231529	Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes
Q39715312	Oligodendroglioma cell lines containing t(1;19)(q10;p10).
Q36272041	Oligodendroglioma: impact of molecular biology on its definition, diagnosis and management
Q59049004	On the Genesis of Neuroblastoma and Glioma
Q42140302	On the origin of glioma
Q64262166	On the subventricular zone origin of human glioblastoma
Q37660428	Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.
Q35889072	Oncogenesis and cancer stem cells: current opinions and future directions
Q30414066	Oncogenic effects of miR-10b in glioblastoma stem cells
Q39007403	Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
Q38552480	Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.
Q37138130	Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61
Q38749871	Oncolytic Virotherapy for the Treatment of Malignant Glioma
Q34109937	Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas
Q36861550	Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells
Q37007756	Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
Q36516586	Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy
Q38212255	Oncolytic viral therapy: targeting cancer stem cells
Q35597082	Oncolytic virotherapy for ovarian cancer
Q81573645	Opinion: the origin of the cancer stem cell: current controversies and new insights
Q55457391	Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.
Q55463378	Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction.
Q41840550	Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry
Q38197503	Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells
Q94564485	Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
Q36848841	Organotropism of breast cancer metastasis
Q48160938	Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme
Q39434238	Organotypic explant culture of glioblastoma multiforme and subsequent single-cell suspension.
Q37861635	Origin and maintenance of the intestinal cancer stem cell
Q37230949	Origins and clinical implications of the brain tumor stem cell hypothesis
Q36577297	Origins of brain tumors--a disease of stem cells?
Q37275730	Ovarian and breast cancer spheres are similar in transcriptomic features and sensitive to fenretinide
Q39725023	Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
Q37033992	Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype
Q47861377	Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
Q35047699	Ovarian cancer stem cells: are they real and why are they important?
Q38013671	Ovarian cancer stem cells: elusive targets for chemotherapy
Q37713683	Ovarian cancer stem cells: still an elusive entity?
Q37589137	Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor
Q36975266	Ovarian cancer: emerging concept on cancer stem cells
Q37461213	Over-expression of Oct4 in human esophageal squamous cell carcinoma
Q39367760	Overactivation of Ras signaling pathway in CD133+ MPNST cells
Q36243367	Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling
Q35036615	Overcoming drug resistance in pancreatic cancer.
Q29248396	Overcoming therapeutic resistance in glioblastoma: the way forward
Q36336437	Overexpression and lack of copy number variation in the BMI-1 gene in human glioma
Q34073309	Overexpression of CD133 promotes drug resistance in C6 glioma cells
Q39662380	Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells
Q90046454	Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas
Q54185735	Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells.
Q39560418	Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors
Q34460630	Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells
Q33648713	Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6
Q29616835	Oxidative stress, inflammation, and cancer: how are they linked?
Q37777514	Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche
Q50089780	PAF promotes stemness and radioresistance of glioma stem cells.
Q40263863	PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.
Q102059097	PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III
Q34778528	PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation.
Q38792223	PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair
Q41708852	PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
Q21245704	PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis
Q38003175	PDGF and PDGF receptors in glioma.
Q42755910	PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation
Q35944343	PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma
Q46592704	PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells
Q64066083	PIP4K2A as a negative regulator of PI3K in PTENdeficient glioblastoma
Q38902920	PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback
Q24615768	PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas
Q38627878	PNIPAAm-co-Jeffamine® (PNJ) scaffolds as in vitro models for niche enrichment of glioblastoma stem-like cells
Q52310328	PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT.
Q30484694	PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells
Q30454765	PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells
Q93022820	PPARδ Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis
Q112297899	PRMT5 inhibition disrupts splicing and stemness in glioblastoma
Q41818544	PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
Q48439393	PTEN Signaling in the Postnatal Perivascular Progenitor Niche Drives Medulloblastoma Formation.
Q36392356	PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
Q37207668	PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Q37270423	PTEN signaling in brain: neuropathology and tumorigenesis.
Q54630382	PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
Q27316304	PTEN-deficient intestinal stem cells initiate intestinal polyposis
Q36003861	PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population
Q38013990	Paediatric and adult malignant glioma: close relatives or distant cousins?
Q37564201	Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy
Q47246307	Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells
Q33648865	Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells
Q84189891	Pancreatic cancer and hedgehog pathway signaling: new insights
Q37952082	Pancreatic cancer stem cell biology and its therapeutic implications
Q37767915	Pancreatic cancer stem cells - update and future perspectives.
Q37590366	Pancreatic cancer stem cells--insights and perspectives
Q38516947	Pancreatic cancer stem cells.
Q37893519	Pancreatic cancer stem cells: new insights and perspectives
Q37473148	Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications
Q35819328	Pancreatic cancer tumour initiating cells: the molecular regulation and therapeutic values
Q33749460	Pancreatic cancer: pathobiology, treatment options, and drug delivery
Q39987316	Paradoxical expression of anti-apoptotic and MRP genes on cancer stem-like cell isolated from TJ905 glioblastoma multiforme cell line
Q40000937	Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme
Q93104522	Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
Q39152617	Pathological features of highly invasive glioma stem cells in a mouse xenograft model
Q39014295	Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding
Q40128801	Patient derived cell culture and isolation of CD133⁺ putative cancer stem cells from melanoma
Q90419003	Patient-Derived Glioma Models: From Patients to Dish to Animals
Q37503365	Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
Q42316508	Patient-derived glioblastoma stem cells respond differentially to targeted therapies
Q34037747	Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century
Q42160720	Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion
Q38957473	Pediatric brain tumor cell lines
Q46496918	Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells
Q47357002	Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures
Q36493813	Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses
Q46280894	Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension
Q47235352	Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins
Q92421241	Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions
Q37407395	Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models
Q34457728	Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Q33317784	Persistence of side population cells with high drug efflux capacity in pancreatic cancer
Q64967797	Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review).
Q28240138	Phage display discovery of novel molecular targets in glioblastoma-initiating cells
Q92364940	Phage display screening of therapeutic peptide for cancer targeting and therapy
Q46164259	Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells
Q38848185	Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells
Q47623927	Pharmacological targeting of apelin impairs glioblastoma growth.
Q50047493	Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
Q35229738	Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study
Q44737792	Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected].
Q24674126	Phenotypic characterization of human colorectal cancer stem cells
Q34540318	Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized
Q34836634	Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Q41830781	Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?
Q39902384	Phosphatidylinositol 3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traffic of ceramide in glioma cells: a link between lipid signaling pathways involved in the control of cell survival.
Q58700460	Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells
Q37459257	Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells
Q28482324	Phosphoproteome of human glioblastoma initiating cells reveals novel signaling regulators encoded by the transcriptome
Q24293124	Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells
Q48105032	Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features
Q35585820	Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.
Q92005572	Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells
Q38510463	Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.
Q24562914	Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics
Q30393905	Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells
Q33760788	Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial
Q42737831	Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
Q42880809	Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells.
Q36020891	Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity
Q33534069	Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironment
Q30942937	Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells
Q34414641	Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation via β-catenin signaling
Q35022551	Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Q34184864	Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
Q37629613	Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer
Q33539425	Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
Q36917797	Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells
Q39251050	Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacy
Q27004658	Positive and negative regulation by NK cells in cancer
Q48746123	Possible involvement of brain tumour stem cells in the emergence of a fast-growing malignant meningioma after surgical resection and radiotherapy of high-grade astrocytoma: case report and preliminary laboratory investigation.
Q99712049	Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells
Q37058454	Potential clinical role of telomere length in human glioblastoma
Q35540034	Potential of Mesenchymal Stem Cell based application in Cancer
Q35180982	Potential of neural stem cells for the treatment of brain tumors
Q39464528	Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells
Q98154720	Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer
Q33965491	Potential therapeutic implications of cancer stem cells in glioblastoma
Q42427923	Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells
Q38972333	Pre-clinical analysis of changes in intra-cellular biochemistry of glioblastoma multiforme (GBM) cells due to c-Myc silencing
Q33278288	Precancerous stem cells have the potential for both benign and malignant differentiation
Q42362521	Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
Q28075903	Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Q38089206	Preclinical development of cancer stem cell drugs
Q36200482	Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes
Q33776755	Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells.
Q93167071	Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis
Q36282985	Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
Q36905859	Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal
Q34770728	Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
Q37996455	Premetastatic niche: ready for new therapeutic interventions?
Q50447091	Preparing Viable Single Cells from Human Tissue and Tumors for Cytomic Analysis.
Q55463437	Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model.
Q48937144	Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.
Q92879597	Preventing the Solid Cancer Progression via Release of Anticancer-Cytokines in Co-Culture with Cold Plasma-Stimulated Macrophages
Q33729734	Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?
Q57298233	Primary cilium and glioblastoma
Q39631460	Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation
Q41565184	Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Q34015722	Primary tumor genotype is an important determinant in identification of lung cancer propagating cells
Q34126555	Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells
Q39559394	Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma
Q34159409	Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.
Q41461769	Processing of primary brain tumor tissue for stem cell assays and flow sorting
Q91639486	Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma
Q81415175	Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells
Q38876097	Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells
Q38966874	Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
Q35000680	Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays
Q42089892	Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells
Q40080387	Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression
Q38806447	Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
Q47127455	Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
Q39662323	Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
Q54378706	Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
Q90376867	Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
Q38399161	Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
Q39393928	Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells
Q36661089	Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
Q34467221	Prognostic value of CD133 expression in stage I lung adenocarcinomas
Q55461475	Prognostic value of Musashi-1 in gliomas.
Q46938693	Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.
Q37194065	Progress in stem cell-derived technologies for hepatocellular carcinoma
Q41890747	Progress in the research on the mechanism of bone metastasis in lung cancer
Q34552547	Progress in understanding melanoma propagation
Q37264332	Progress on potential strategies to target brain tumor stem cells.
Q34205351	Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds
Q83012243	Proliferation characteristics of CD133+ cell population in colorectal cancer
Q41822073	Proliferation versus regeneration: the good, the bad and the ugly
Q48245311	Prolonged exposure to doxorubicin after radiotherapy in glioblastoma
Q34907204	Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
Q34701002	Prominin 1/CD133 endothelium sustains growth of proneural glioma
Q35237532	Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas
Q42475870	Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate.
Q48163938	Prominin-1 allows prospective isolation of neural stem cells from the adult murine hippocampus.
Q37995024	Promises and challenges of exhausting pediatric neural cancer stem cells
Q90352807	Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
Q46446472	Promoter hypomethylation regulates CD133 expression in human gliomas
Q39166290	Promotion of epithelial-mesenchymal transition and tumor growth by 17β-estradiol in an ER(+)/HER2(+) cell line derived from human breast epithelial stem cells
Q92862398	Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles
Q48592096	Proneural-mesenchymal transformation of glioma stem cells: do therapies cause evolution of target in glioblastoma?
Q34689170	Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.
Q37596687	Properties and feasibility of using cancer stem cells in clinical cancer treatment
Q37768058	Properties and identification of cancer stem cells: a changing insight into intractable cancer
Q34203720	Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors
Q28257733	Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells
Q34786609	Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo
Q42278310	Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties
Q36943338	Prospective isolation and functional analysis of stem and differentiated cells from the mouse mammary gland
Q34188715	Prospective isolation of clonogenic mantle cell lymphoma-initiating cells
Q37139272	Prostate cancer and metastasis initiating stem cells
Q37144101	Prostate cancer stem cell therapy: hype or hope?
Q57133950	Prostate cancer stem cells
Q37863626	Prostate cancer stem cells and their potential roles in metastasis
Q36994174	Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells
Q36318592	Prostate epithelial stem cells.
Q42498759	Prostate stem cells and prostate cancer
Q39592000	Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference
Q35048997	Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence.
Q48259049	Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
Q48422165	Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells.
Q33859479	Proteome of human colon cancer stem cells: a comparative analysis
Q39171812	Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells
Q36044393	Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species
Q41377207	Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.
Q47566392	Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.
Q89604984	Purinergic Signaling in Glioma Progression
Q33635374	Pyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas
Q90480120	Quantification of the Underlying Mechanisms and Relationships Among Cancer, Metastasis, and Differentiation and Development
Q36010140	Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas
Q37628648	Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres
Q36398251	Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy
Q36202012	Quantitative evaluation of malignant gliomas damage induced by photoactivation of IR700 dye.
Q99594561	Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts
Q39034542	Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells
Q35635358	Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma
Q37799253	Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance
Q38752182	RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.
Q37042217	RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation
Q34305458	REST controls self-renewal and tumorigenic competence of human glioblastoma cells
Q35127614	RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule
Q35172957	RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells
Q28481458	RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways
Q48001574	RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
Q34141445	RNAi-mediated knockdown of E2F2 inhibits tumorigenicity of human glioblastoma cells
Q58554039	RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma
Q36356040	RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop
Q36260652	RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK.
Q38721422	RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway
Q38981266	Rab3a promotes brain tumor initiation and progression
Q33828696	Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity
Q90729481	Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells
Q37406832	Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance
Q34131280	Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited
Q53543624	Radiation responses of stem cells: targeted and non-targeted effects.
Q38431453	Radiation therapy for glioma stem cells
Q38331970	Radiation treatment and cancer stem cells
Q91711337	Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma
Q49251128	Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA.
Q37299525	Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report
Q41279707	Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice
Q35214639	Radioresistance of cancer stem-like cell derived from canine tumours
Q37887286	Radioresistance of glioma stem cells: intrinsic characteristic or property of the 'microenvironment-stem cell unit'?
Q46319689	Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program
Q37237361	Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology)
Q35587475	Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition.
Q47849042	Radiotherapy and Glioma Stem Cells: Searching for Chinks in Cellular Armor
Q48670149	Rai is a new regulator of neural progenitor migration and glioblastoma invasion.
Q33574964	Rapamycin induces differentiation of glioma stem/progenitor cells by activating autophagy
Q41594903	Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors
Q39393647	Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
Q26849216	Reactive oxygen species in cancer stem cells
Q28484418	Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition
Q64061376	Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
Q35459525	Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers
Q37310063	Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications
Q37089825	Recent progress on tissue-resident adult stem cell biology and their therapeutic implications
Q36907427	Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway
Q42317550	Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
Q37461075	Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.
Q36321176	Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma
Q90009669	Recombinant collagenase from Grimontia hollisae as a tissue dissociation enzyme for isolating primary cells
Q34362205	Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.
Q39004963	Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells
Q33960280	Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression
Q38920534	Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.
Q36668246	Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates
Q36503827	Redefining cellular phenotypy based on embryonic, adult, and cancer stem cell biology
Q26774916	Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance
Q34017894	Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene
Q36773450	Regeneration and plasticity in the brain and spinal cord
Q58572812	Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway
Q38082722	Regulation and dysregulation of astrocyte activation and implications in tumor formation
Q36700030	Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
Q92358445	Regulation of Osteosclerosis by Inoculated Cd133+ PC3 Cells in Bone-marrow Microenvironmental Niches
Q38852157	Regulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins.
Q39752820	Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
Q38359738	Regulation of breast cancer stem cell features
Q90117523	Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer
Q36579270	Regulation of cell lineage specification by the retinoblastoma tumor suppressor
Q37640483	Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
Q33587316	Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.
Q38030660	Regulation of self-renewal in normal and cancer stem cells.
Q37513688	Regulation of stem cell populations by microRNAs
Q38264665	Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
Q37020846	Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells
Q36583430	Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions
Q55461205	Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells.
Q41448649	Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex
Q36013331	Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype
Q48198632	Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis
Q33484184	Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy
Q36517050	Repair and regeneration: opportunities for carcinogenesis from tissue stem cells
Q93376481	Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells
Q38280712	Reprogramming by lineage specifiers: blurring the lines between pluripotency and differentiation
Q36769827	Reprogramming metastatic tumour cells with embryonic microenvironments
Q93156088	Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
Q36524716	Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
Q28816972	Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
Q38794082	Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma
Q47151420	Research on human glioma stem cells in China
Q41772946	Resident stem cells and renal carcinoma
Q35654300	Residual tumor cells are unique cellular targets in glioblastoma
Q30313560	Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest
Q37689095	Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy
Q39954297	Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins
Q37002770	Resistance of papillary thyroid cancer stem cells to chemotherapy
Q54598200	Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.
Q37404590	Resistance to endocrine therapy: are breast cancer stem cells the culprits?
Q39245618	Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro.
Q37580498	Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype
Q34277599	Response-predictive gene expression profiling of glioma progenitor cells in vitro
Q35586066	Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.
Q36247757	Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway
Q48622244	Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Q28484528	Retracted: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats
Q34613006	Retracted: Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines
Q28547688	Retracted: Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties
Q37665234	Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a disco
Q37476480	Review paper: Implications of the "cancer stem cell" hypothesis on murine models of colon cancer and colitis-associated cancer
Q38008694	Review: developmental origins of neural tumours: old idea, new approaches.
Q33925544	Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
Q52668450	Revisit the Candidacy of Brain Cell Types as the Cell(s) of Origin for Human High-Grade Glioma.
Q39190733	Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
Q37814038	Revisiting the concept of cancer stem cells in prostate cancer.
Q37463413	Revisiting the seed and soil in cancer metastasis
Q37641648	RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells
Q35823287	Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Q37012033	Road for understanding cancer stem cells: model cell lines
Q47137381	Road to stemness in hepatocellular carcinoma
Q42437104	Robust expression of Prominin-2 all along the adult male reproductive system and urinary bladder
Q57470592	Role of AhR in Regulating Cancer Stem Cell-like Characteristics in Choriocarcinoma
Q52666361	Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal.
Q36946578	Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
Q57596254	Role of Cancer Stem Cells in Metastasis
Q26860972	Role of Eph/ephrin tyrosine kinase in malignant glioma
Q48310787	Role of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models.
Q26860974	Role of SOX family of transcription factors in central nervous system tumors
Q38693644	Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis
Q37591417	Role of TGF-β in breast cancer bone metastases.
Q37846254	Role of cancer stem cells in hepatocarcinogenesis
Q37993701	Role of cancer stem cells in spine tumors: review of current literature
Q38289553	Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells
Q38027227	Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy
Q90296572	Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study
Q26750359	Role of nuclear receptors in breast cancer stem cells
Q28088349	Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis
Q33883849	Role of receptor tyrosine kinases and their ligands in glioblastoma
Q54384404	Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells.
Q35846826	Role of stem cells in cancer therapy and cancer stem cells: a review
Q37995020	Role of stemness-related molecules in neuroblastoma
Q34253642	Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells
Q36677847	Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
Q36665179	Role of the microenvironment in ovarian cancer stem cell maintenance
Q37359959	Roles of TGF-beta family signaling in stem cell renewal and differentiation
Q38973408	Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line
Q47211731	Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells
Q38025085	Roles of p53 in various biological aspects of hematopoietic stem cells
Q92973948	SERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types
Q47885098	SHP2 regulates proliferation and tumorigenicity of glioma stem cells.
Q23920671	SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma
Q38373829	SOX2 immunity and tissue resident memory in children and young adults with glioma
Q34022836	SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity
Q39574549	SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell
Q49382495	SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance.
Q28244307	SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma
Q89604998	STAT Signaling in Glioma Cells
Q90400267	STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
Q36559375	STAT3 is Overactivated in Gastric Cancer Stem-Like Cells
Q54427862	STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Q35757920	STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.
Q37550760	STAT3 regulation of glioblastoma pathogenesis.
Q43068296	STAT3 tyrosine phosphorylation influences survival in glioblastoma
Q33876908	SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression
Q59798408	SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines
Q38224211	Safely targeting cancer stem cells via selective catenin coactivator antagonism
Q35111314	Salinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells
Q38117949	Salivary gland cancer stem cells
Q36982130	Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice
Q50334475	Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System.
Q37195569	Scalable Production of Glioblastoma Tumor-initiating Cells in 3 Dimension Thermoreversible Hydrogels
Q40555585	Screening glioma stem cells in U251 cells based on the P1 promoter of the CD133 gene
Q42206208	Searching for adult stem cells in the intestine
Q38768259	Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.
Q42728935	Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.
Q42150559	Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity
Q47444311	Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
Q38110297	Seed, soil, and beyond: The basic biology of brain metastasis
Q34978487	Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology?
Q34451968	Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.
Q39798412	Selective enrichment of hepatocellular cancer stem cells by chemotherapy
Q27318247	Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells
Q30987402	Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens
Q28474745	Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors
Q41070253	Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells
Q33398823	Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas
Q34388958	Self-renewal as a therapeutic target in human colorectal cancer.
Q50511855	Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
Q34714664	Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation
Q39333626	Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation
Q41127576	Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells
Q38802705	Senescence from glioma stem cell differentiation promotes tumor growth
Q38601722	Sensitivity to BUB1B inhibition defines an alternative classification of glioblastoma
Q37069461	Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Q28115436	Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Q61805903	Serum erythropoietin levels, breast cancer and breast cancer-initiating cells
Q28551757	Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9
Q40883588	Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas
Q26864979	Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition
Q52141064	Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures.
Q37797464	Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
Q62558147	Side population (SP) cells: Taking center stage in regeneration and liver cancer?
Q34254605	Side population cells from HXO-Rb44 retinoblastoma cell line have cancer-initiating property
Q39787753	Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas
Q36214625	Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics
Q33955804	Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells
Q35192383	Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis
Q36789564	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
Q39816595	Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination.
Q40262786	Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties
Q35233174	Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells
Q37637707	Signaling in malignant astrocytomas: role of neural stem cells and its therapeutic implications.
Q26827171	Significance and therapeutic value of miRNAs in embryonal neural tumors
Q30397723	Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma
Q38468235	Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
Q58711755	Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
Q38689740	Significance of low mTORC1 activity in defining the characteristics of brain tumor stem cells
Q42725487	Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
Q49799823	Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway.
Q38292242	Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells
Q90361446	Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies
Q90029634	Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore
Q37644953	Simultaneous targeting of Eph receptors in glioblastoma
Q36575238	Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma
Q35031305	Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Q37480399	Single doublecortin gene therapy significantly reduces glioma tumor volume
Q34650297	Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts
Q92447495	Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells
Q29615604	Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Q97534241	Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Q93123481	Single-cell RNA-seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression
Q34346611	Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
Q37706665	Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness
Q35021326	Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway
Q33533313	Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice
Q36252493	Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration.
Q38642010	Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB.
Q38156189	Small cell carcinoma of the urinary bladder: a contemporary review with a special focus on bladder-sparing treatments
Q39070550	Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin
Q42321107	Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.
Q38088823	Smoothened antagonists: a promising new class of antitumor agents
Q58707604	Soft Tissue Sarcoma Cancer Stem Cells: An Overview
Q38724729	Soft matrices downregulate FAK activity to promote growth of tumor-repopulating cells.
Q36605667	Somatic stem cells and the origin of cancer
Q58795103	Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks
Q39521830	Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.
Q36654402	Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Q99718033	Sox2-dependent maintenance of mouse oligodendroglioma involves the Sox2-mediated downregulation of Cdkn2b, Ebf1, Zfp423, and Hey2
Q39184953	Sox21 inhibits glioma progression in vivo by forming complexes with Sox2 and stimulating aberrant differentiation
Q48948503	Sparing of the hippocampus, limbic circuit and neural stem cell compartment during partial brain radiotherapy for glioma: a dosimetric feasibility study.
Q34749277	Spatial distribution of prominin-1 (CD133)-positive cells within germinative zones of the vertebrate brain
Q47726425	Specific Preferences in Lineage Choice and Phenotypic Plasticity of Glioma Stem Cells Under BMP4 and Noggin Influence.
Q36284380	Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging
Q42863043	Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors
Q34478093	Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells
Q36424175	Sphere-forming tumor cells possess stem-like properties in human fibrosarcoma primary tumors and cell lines
Q61796403	Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells
Q39228334	Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties
Q92541731	Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics
Q36024608	Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
Q30052394	Spheroid-based drug screen: considerations and practical approach
Q64388225	Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
Q45324743	Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program
Q33316454	Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade
Q37399843	Squelching glioblastoma stem cells by targeting REST for proteasomal degradation
Q64272956	Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Q49452242	Stem Cell Metabolism in Cancer and Healthy Tissues: Pyruvate in the Limelight.
Q26795447	Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century
Q45297477	Stem and progenitor cell-based therapy of the human central nervous system.
Q37745783	Stem cell cultures derived from pediatric brain tumors accurately model the originating tumors.
Q39950869	Stem cell labeling using polyethylenimine conjugated (α-NaYbF4:Tm3+)/CaF2 upconversion nanoparticles.
Q37169144	Stem cell markers in gliomas
Q35789091	Stem cell niche dynamics: from homeostasis to carcinogenesis.
Q37513808	Stem cell origins and animal models of hepatocellular carcinoma
Q26746223	Stem cell technology in breast cancer: current status and potential applications
Q64110008	Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
Q38170621	Stem cell-directed therapies in pancreatic cancer
Q36943373	Stem cells and TCF proteins: a role for beta-catenin--independent functions
Q36144886	Stem cells and brain cancer
Q59530485	Stem cells and brain cancer
Q36979034	Stem cells and cancer: an overview
Q38235856	Stem cells and gliomas: past, present, and future.
Q29620450	Stem cells and niches: mechanisms that promote stem cell maintenance throughout life
Q26825014	Stem cells and targeted approaches to melanoma cure
Q36907525	Stem cells and the origin and propagation of brain tumors
Q38160452	Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements.
Q37835709	Stem cells and their implications for colorectal cancer.
Q37985376	Stem cells in brain tumour development and therapy- two-sides of the same coin.
Q37777341	Stem cells in colon cancer. A new era in cancer theory begins
Q27027153	Stem cells in gastric cancer
Q33989211	Stem cells in gastroenterology and hepatology
Q38271602	Stem cells in gastrointestinal cancers: The road less travelled
Q37799828	Stem cells in gastrointestinal cancers: a matter of choice in cell fate determination
Q64100357	Stem cells in homeostasis and cancer of the gut
Q36117797	Stem cells in melanoma development
Q91977175	Stem cells in tissues, organoids, and cancers
Q24653517	Stem cells of ependymoma
Q43065114	Stem cells, a two-edged sword: risks and potentials of regenerative medicine
Q37936212	Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target.
Q64979688	Stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool.
Q38041726	Stem-like cells and therapy resistance in squamous cell carcinomas
Q34769927	Stem-like cells in bone sarcomas: implications for tumorigenesis
Q26741641	Stem-like features of cancer cells on their way to metastasis
Q36123668	Stem/progenitor cells in mouse mammary gland development and breast cancer.
Q37193824	Stemming cancer: functional genomics of cancer stem cells in solid tumors
Q34269290	Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro
Q47176774	Stemness-Related Markers in Cancer
Q37079078	Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors.
Q52597602	Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1.
Q81234707	Stochastic model of the formation of cancer metastases via cancer stem cells
Q37061915	Strategies for isolating and enriching cancer stem cells: well begun is half done
Q52686102	Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer.
Q42787521	Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors
Q39318528	Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays.
Q91650623	Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance
Q43043463	Study on the proliferation and drug-resistance of human brain tumor stem-like cells
Q37664046	Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo
Q34129056	Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures
Q33582057	Subventricular zones: new key targets for glioblastoma treatment
Q35695799	Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation
Q40053661	Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma.
Q33842071	Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells
Q34120438	Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition
Q35090120	Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Q36739421	Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis.
Q49544688	Surface Markers for the Identification of Cancer Stem Cells.
Q41064474	Surface free energy activated high-throughput cell sorting
Q35742283	Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26.
Q33892946	Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment
Q36123682	Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia
Q36087138	Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
Q37186425	Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis
Q35133489	Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development
Q91707747	Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists
Q46549141	Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients
Q52097904	Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
Q50154429	Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.
Q28834689	Synthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer Cells
Q37109769	Systematic characterization of lncRNAs' cell-to-cell expression heterogeneity in glioblastoma cells
Q34043017	Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent
Q37010408	Systems biology and cancer stem cells
Q28474262	T cells enhance stem-like properties and conditional malignancy in gliomas
Q35369863	TCR-dependent transformation of mature memory phenotype T cells in mice
Q49802266	TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Q92297968	TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER
Q37670250	TGF-beta signalling and immunity in prostate tumourigenesis
Q28274611	TGF-β family signaling in stem cells
Q37900199	TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases
Q36818228	TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells
Q57476481	TLR4 Polymorphisms and Expression in Solid Cancers
Q42600801	TLRs, Alcohol, HCV, and Tumorigenesis
Q34619422	TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.
Q33743051	TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
Q37154265	TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth
Q34523263	Tackling the cancer stem cells - what challenges do they pose?
Q36343524	Target for cancer therapy: proliferating cells or stem cells
Q38438756	Targetable T-type Calcium Channels Drive Glioblastoma
Q37730943	Targeted Nanotechnology in Glioblastoma Multiforme.
Q36786085	Targeted cancer therapy: promise and reality
Q41942526	Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer
Q42575761	Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival
Q47935571	Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Q35802983	Targeted therapy against cancer stem cells
Q38114000	Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example
Q48656969	Targeted therapy for malignant glioma: neural stem cells.
Q35832224	Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
Q33534629	Targeting A20 decreases glioma stem cell survival and tumor growth
Q36460465	Targeting Axl with an high-affinity inhibitory aptamer.
Q37521082	Targeting CD133 antigen in cancer
Q37615744	Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy
Q86419308	Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells
Q41463557	Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.
Q94545537	Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Q37981764	Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.
Q26741846	Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Q92912613	Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Q38566898	Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
Q89510879	Targeting Glutamine Addiction in Gliomas
Q34887224	Targeting HIF1α eliminates cancer stem cells in hematological malignancies.
Q38750432	Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine
Q39321673	Targeting Lung Cancer Stem Cells: Research and Clinical Impacts
Q36544248	Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors
Q48502109	Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.
Q37763414	Targeting Notch to target cancer stem cells.
Q35750188	Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
Q48873732	Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
Q28079501	Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
Q37710226	Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
Q36421110	Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
Q42602597	Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.
Q48678789	Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Q37736255	Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Q48279526	Targeting brain-tumor stem cells
Q34505105	Targeting breast cancer stem cells
Q36953575	Targeting cancer cells with the natural compound obtusaquinone.
Q89667670	Targeting cancer stem cell pathways for cancer therapy
Q38937280	Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
Q37820099	Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Q37061986	Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential.
Q38099729	Targeting cancer stem cells for treatment of glioblastoma multiforme
Q37229281	Targeting cancer stem cells in cancer prevention and therapy
Q92512238	Targeting cancer stem cells in drug discovery: Current state and future perspectives
Q35181108	Targeting cancer stem cells in solid tumors by vitamin D.
Q90620359	Targeting cancer stem cells in squamous cell carcinoma
Q42547900	Targeting cancer stem cells through L1CAM suppresses glioma growth
Q38149736	Targeting cancer stem cells to suppress acquired chemotherapy resistance
Q37206241	Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis
Q36871985	Targeting cancer stem cells.
Q37170030	Targeting cancer stem cells: emerging role of Nanog transcription factor
Q38889490	Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways
Q34659011	Targeting cancer-initiating cells with oncolytic viruses
Q35125616	Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.
Q36653149	Targeting gene-virotherapy of cancer and its prosperity
Q47648829	Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Q27026818	Targeting glioma stem cells: a novel framework for brain tumors
Q47845301	Targeting glioma stem-like cell survival and chemo-resistance through inhibition of lysine-specific histone demethylase KDM2B.
Q35236465	Targeting histone methyltransferase EZH2 as cancer treatment
Q33674790	Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth
Q43239168	Targeting metabolism to induce cell death in cancer cells and cancer stem cells
Q37144023	Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers
Q38916554	Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo
Q26865693	Targeting prostate cancer stem cells for cancer therapy
Q39459345	Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines
Q39438509	Targeting radioresistant osteosarcoma cells with parthenolide
Q37689120	Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis
Q42689215	Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.
Q64119664	Targeting stem cells in the realm of drug-resistant breast cancer
Q92652651	Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
Q37493686	Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment
Q92446113	Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
Q49425250	Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations.
Q39400127	Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics
Q38981263	Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
Q34688767	Targeting the embryonic gene Cripto-1 in cancer and beyond
Q34218232	Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis
Q34335524	Targeting the osteosarcoma cancer stem cell
Q36394964	Targeting the perpetrator: breast cancer stem cell therapeutics
Q37702117	Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer
Q34089425	Targeting unique metabolic properties of breast tumor initiating cells
Q91726670	Targeting β2 subunit of Na+/K+-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca2
Q37272169	Techniques for following labeled cells in vivo: use of X/Y FISH, techniques to optimize fluorescent detection, and beta-galactosidase detection
Q37532245	Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression
Q34569385	Telomerase and cancer stem cells
Q39853352	Telomerase downregulation in cancer brain stem cell
Q42479312	Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein
Q50054937	Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.
Q35060849	Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays
Q95841422	Tep1 Regulates Yki Activity in Neural Stem Cells in Drosophila Glioma Model
Q55309955	The Adenosine A₃ Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia.
Q92454911	The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies
Q34738018	The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers.
Q39458532	The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation
Q39561175	The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma
Q41871003	The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma.
Q41789674	The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma.
Q36996128	The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
Q42135962	The CML stem cell: evolution of the progenitor
Q41971146	The Cancer Stem Cell Fraction in Hierarchically Organized Tumors Can Be Estimated Using Mathematical Modeling and Patient-Specific Treatment Trajectories.
Q92126767	The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
Q64990834	The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis.
Q41283587	The Crossroads of Neural Stem Cell Development and Tumorigenesis
Q92070076	The Curious Case of ZEB1
Q37977004	The DNA damage response and cancer therapy
Q52651301	The DNA-PK inhibitor VX-984 enhances the radiosensitivity of glioblastoma cells grown in vitro and as orthotopic xenografts.
Q38870811	The Effects of Thermal Preconditioning on Oncogenic and Intraspinal Cord Growth Features of Human Glioma Cells
Q37134198	The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.
Q90195094	The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior
Q33842621	The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells
Q46136392	The Future of Radiobiology.
Q34685494	The Gli code: an information nexus regulating cell fate, stemness and cancer.
Q48220409	The HDAC6 Inhibitor Tubacin Induces Release of CD133+ Extracellular Vesicles From Cancer Cells.
Q102152114	The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions
Q101133357	The HIF1α/JMY pathway promotes glioblastoma stem-like cell invasiveness after irradiation
Q41694131	The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy.
Q38542016	The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.
Q35858416	The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes.
Q38652319	The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells
Q38645695	The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
Q40097895	The Implications of the Cancer Stem Cell Hypothesis for Neuro-Oncology and Neurology
Q47134413	The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model
Q35941495	The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells
Q37008901	The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches
Q26750605	The NF-κB Pathway and Cancer Stem Cells
Q39659982	The Neural Stem Cell Fate Determinant TLX Promotes Tumorigenesis and Genesis of Cells Resembling Glioma Stem Cells
Q27315124	The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer
Q36971953	The Notch signaling pathway as a mediator of tumor survival
Q42397528	The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells
Q58766021	The Pathophysiology of Post-Traumatic Glioma
Q60320612	The Plasticity of Stem-Like States in Patient-Derived Tumor Xenografts
Q47834398	The Pro-tumorigenic Effects of Metabolic Alterations in Glioblastoma Including Brain Tumor Initiating Cells
Q64078996	The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
Q90175728	The Quiescent Metabolic Phenotype of Glioma Stem Cells
Q90179401	The Role of Cancer Stem Cells in Radiation Resistance
Q26767061	The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis
Q36300487	The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
Q90423341	The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology
Q46141259	The Role of Nitric Oxide from Neurological Disease to Cancer
Q44033285	The Role of Protein Kinase B Signaling Pathway in Anti-Cancer Effect of Rolipram on Glioblastoma Multiforme: An In Vitro Study
Q92757181	The Role of SVZ Stem Cells in Glioblastoma
Q37732532	The Role of Snail in EMT and Tumorigenesis
Q36562896	The Role of chemokine receptor CXCR4 in breast cancer metastasis
Q27005618	The Role of microRNAs in Stemness of Cancer Stem Cells
Q33769624	The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis
Q37275598	The Stem Cell Network model: clinical implications in cancer
Q38940139	The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences
Q38699352	The Wnt signaling pathway in cancer
Q34632285	The Wnt signaling pathway: implications for therapy in osteosarcoma
Q36674940	The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells
Q39188696	The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways
Q35770218	The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
Q37018171	The availability of the embryonic TGF-β protein Nodal is dynamically regulated during glioblastoma multiforme tumorigenesis
Q42071847	The battle for the brain: Brain tumor-initiating cells vs. microglia/macrophages
Q35778321	The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma
Q37954461	The biology of head and neck cancer stem cells
Q35773205	The bone marrow microenvironment as a sanctuary for minimal residual disease in CML.
Q35836051	The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells
Q39256222	The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles
Q33567109	The cancer stem cell concept in progression of head and neck cancer
Q36639832	The cancer stem cell hypothesis: a work in progress
Q37816878	The cancer stem cell hypothesis: failures and pitfalls.
Q53308300	The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
Q37628729	The cancer stem cell microenvironment and anti-cancer therapy.
Q36854372	The cancer stem cell paradigm: a new understanding of tumor development and treatment
Q42098955	The cancer stem cell phenotype: You can't win until you learn how to lose it
Q37257519	The cancer stem cell theory: is it correct?
Q37851011	The cancer stem cell: premises, promises and challenges
Q55463049	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Q36546538	The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.
Q37909375	The clinical and therapeutic implications of cancer stem cell biology
Q38008153	The clinical implications of medulloblastoma subgroups
Q37562052	The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells
Q64063271	The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations
Q58748412	The complement system in glioblastoma multiforme
Q38230516	The continuing evolution: biology and treatment of brain tumors.
Q37321944	The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.
Q35566484	The crossroads between cancer stem cells and aging.
Q26782620	The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
Q55399267	The developmental origin of brain tumours: a cellular and molecular framework.
Q34105402	The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
Q92980181	The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis
Q28744461	The difficulty of targeting cancer stem cell niches
Q58771698	The effects of extra high dose rate irradiation on glioma stem-like cells
Q38990450	The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.
Q36070194	The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model
Q37725428	The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Q29617486	The epigenetic progenitor origin of human cancer
Q24650786	The epithelial-mesenchymal transition generates cells with properties of stem cells
Q37401193	The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies
Q30300892	The evidence of glioblastoma heterogeneity
Q40538740	The evolution of cancer modeling: the shadow of stem cells.
Q37120960	The evolution of our understanding on glioma
Q34460364	The evolving cancer stem cell paradigm: implications in veterinary oncology
Q36145729	The evolving concept of cancer and metastasis stem cells
Q33652614	The evolving landscape of glioblastoma stem cells
Q36997962	The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors
Q39396381	The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the cell line A172.
Q37109240	The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.
Q92287159	The feasibility of using dielectrophoresis for isolation of glioblastoma subpopulations with increased stemness
Q34132722	The functional role of Notch signaling in human gliomas
Q38048888	The future of glioma treatment: stem cells, nanotechnology and personalized medicine
Q38861930	The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
Q36810356	The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms
Q38045265	The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
Q36836595	The hunt for cancer-initiating cells: a history stemming from leukemia
Q39554922	The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion
Q33674720	The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
Q37450220	The identification of human pituitary adenoma-initiating cells
Q38109711	The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment
Q28388257	The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis
Q36760027	The impact of translocations and gene fusions on cancer causation
Q36538487	The implications of cancer stem cells for cancer therapy
Q33707208	The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth
Q33862363	The increasing complexity of the cancer stem cell paradigm
Q33598447	The inflammatory cytokine IL-22 promotes murine gliomas via proliferation
Q37266187	The interface between glial progenitors and gliomas
Q36493820	The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities
Q37217105	The intestinal stem cell
Q36602158	The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets
Q37603012	The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-like cells?
Q38957401	The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
Q39656326	The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction
Q36778291	The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype
Q37409754	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
Q38026421	The malignant social network: cell-cell adhesion and communication in cancer stem cells
Q36971718	The microenvironment of the embryonic neural stem cell: lessons from adult niches?
Q27012559	The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death
Q38242892	The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition
Q89897822	The necessity for standardization of glioma stem cell culture: a systematic review
Q36788944	The neural crest: understanding stem cell function in development and disease
Q97074811	The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant glioma
Q37910730	The neurobiology of gliomas: from cell biology to the development of therapeutic approaches
Q39489252	The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway
Q36907124	The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
Q42056934	The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
Q39889217	The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation
Q33779457	The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking
Q27334481	The p75 neurotrophin receptor is a central regulator of glioma invasion
Q50981882	The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Q47719741	The potential of the brain: plasticity implications for de-differentiation of mature astrocytes.
Q27005807	The potential origin of glioblastoma initiating cells
Q38477694	The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas
Q37346067	The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
Q45801884	The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis
Q37636662	The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
Q36926655	The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group
Q39414023	The regulation of tumor cell physiology by mitochondrial dynamics
Q35777808	The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy.
Q29620694	The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
Q52315005	The ribosome, (slow) beating heart of cancer (stem) cell.
Q89467746	The role of CD133 in cancer: a concise review
Q24646816	The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
Q36429628	The role of Wnt signaling in cancer and stem cells
Q37476789	The role of autophagy in sensitizing malignant glioma cells to radiation therapy
Q45863982	The role of cancer stem cells (CD133(+)) in malignant gliomas
Q36405638	The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies
Q37327833	The role of cancer stem cells in neoplasia of the lung: past, present and future
Q38015703	The role of epigenetic regulation in stem cell and cancer biology
Q36795940	The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Q37811959	The role of human aldehyde dehydrogenase in normal and cancer stem cells
Q30428370	The role of microRNAs in glioma initiation and progression
Q37428403	The role of microRNAs in the regulation of cancer stem cells
Q38770247	The role of octamer binding transcription factors in glioblastoma multiforme
Q37863625	The role of stem and circulating cells in cancer metastasis
Q33678542	The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells
Q38632898	The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development
Q38175044	The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development
Q52680707	The role of the mitochondria and the endoplasmic reticulum contact sites in the development of the immune responses.
Q52583504	The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
Q37964588	The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis
Q38044698	The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates
Q38263985	The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells
Q50954845	The sixth annual translational stem cell research conference of the New York Stem Cell Foundation.
Q44704611	The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action.
Q39056846	The taxonomy of brain cancer stem cells: what's in a name?
Q39756110	The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth
Q33559711	The therapeutic promise of the cancer stem cell concept
Q37946457	The three M's: melanoma, microphthalmia-associated transcription factor and microRNA.
Q26829663	The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications
Q37338389	The transcription factor ATF5: role in neurodevelopment and neural tumors
Q38776367	The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma
Q39366432	The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation
Q43585250	The tumor growth paradox and immune system-mediated selection for cancer stem cells
Q39231689	The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells
Q35202314	The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma
Q34785119	The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
Q35147171	The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells
Q26744724	Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells
Q38742530	Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.
Q36030226	Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
Q39171149	Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
Q36103152	Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance.
Q38310587	Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Q38637435	Therapeutic antibodies against cancer stem cells: a promising approach
Q37137412	Therapeutic approaches to target cancer stem cells
Q37526996	Therapeutic implications of Cancer Initiating Cells
Q37403285	Therapeutic implications of the cancer stem cell hypothesis.
Q35613323	Therapeutic potential of AZD1480 for the treatment of human glioblastoma
Q38446739	Therapeutic potential of cancer stem cells
Q36636067	Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.
Q38942907	Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumour coming back
Q33426563	Therapeutic strategies for inhibiting invasion in glioblastoma
Q37475476	Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells
Q36619069	Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
Q34154786	Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms
Q47733392	Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.
Q50069637	Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans.
Q33748280	Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma
Q36579481	Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage
Q37905534	Thyroid cancer stem cells
Q48570682	Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker?
Q39855649	Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters
Q37424830	Time-lapse live imaging of stem cells in Drosophila testis
Q37633126	Tissue-specific targeting based on markers expressed outside endothelial cells
Q34025911	Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells
Q35150426	Toward an Ising model of cancer and beyond
Q33560685	Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors
Q30445250	Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
Q37815132	Tracing the origins of metastasis
Q33998432	Tracing the tumor lineage
Q45938874	Tracking Functional Tumor Cell Subpopulations of Malignant Glioma by Phasor Fluorescence Lifetime Imaging Microscopy of NADH.
Q37522979	Transcription factors and neural stem cell self-renewal, growth and differentiation
Q42200666	Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of Endometrial Adenocarcinoma
Q50051205	Transcriptional Regulation of Stem Cell and Cancer Stem Cell Metabolism.
Q38509836	Transcriptional and functional defects of dendritic cells derived from the MUTZ-3 leukaemia line
Q39145031	Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.
Q36349927	Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
Q57471352	Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation
Q42544373	Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas
Q41512201	Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value
Q52727607	Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
Q40252270	Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Q38469127	Transforming growth factor β and bone morphogenetic protein actions in brain tumors
Q38192972	Transforming growth factor-beta and its implication in the malignancy of gliomas
Q38993232	Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer
Q35851931	Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells
Q99615822	Translational cancer biology
Q37137006	Translational research in glioblastoma multiforme: molecular criteria for patient selection.
Q24656327	Transparent adult zebrafish as a tool for in vivo transplantation analysis
Q36397803	Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells
Q40148472	Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma
Q54360289	Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Q36943893	Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin
Q36663418	Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus
Q37129807	Treatment resistance mechanisms of malignant glioma tumor stem cells
Q39264794	Trending Speculations of Tumor-Initiating Cells in Squamous Cell Cancers of Head and Neck
Q103826175	Trends and challenges in modeling glioma using 3D human brain organoids
Q42001741	Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
Q39256859	Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
Q34631363	Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation
Q37580396	TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells
Q37016384	Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics
Q90361830	Tumor Cell Invasion in Glioblastoma
Q27318628	Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies
Q35110178	Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients
Q38194970	Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance.
Q28478733	Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44
Q37384328	Tumor initiating cells in malignant gliomas: biology and implications for therapy
Q36705901	Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation
Q33258175	Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling
Q37269232	Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma
Q91698193	Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Q36081389	Tumor suppressors Sav/Scrib and oncogene Ras regulate stem-cell transformation in adult Drosophila malpighian tubules
Q37649057	Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Q39675480	Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor
Q37774865	Tumor-initiating and -propagating cells: cells that we would like to identify and control
Q37687644	Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness
Q33999375	Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor.
Q34156000	Tumor-initiating cells are rare in many human tumors
Q42425960	Tumor-initiating cells: an influential paradigm for xenograft research
Q36382795	Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division
Q41196091	Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.
Q34044078	Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner
Q35055173	Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity
Q35774333	Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions
Q34358461	Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines
Q33408177	Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1
Q33488882	Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma
Q90364706	Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Q39413649	Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties
Q38757923	Tumour angiogenesis-Origin of blood vessels
Q35165685	Tumour control probability in cancer stem cells hypothesis
Q29617990	Tumour heterogeneity and cancer cell plasticity
Q29617742	Tumour stem cells and drug resistance
Q101216977	Tumour treating fields therapy for glioblastoma: current advances and future directions
Q34151513	Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Q36273372	Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
Q37606286	Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Q37285008	Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways
Q24657250	Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression
Q37636754	Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells
Q26849613	Twisted tango: brain tumor neurovascular interactions
Q34381578	Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
Q39011254	Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells
Q36603152	Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas
Q92289585	UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts
Q36367391	USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance
Q42379765	USP11 regulates PML stability to control Notch-induced malignancy in brain tumours.
Q92928321	USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells
Q30352749	Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma
Q36907405	Understanding and targeting cancer stem cells: therapeutic implications and challenges
Q35796886	Understanding cancer stem cell heterogeneity and plasticity.
Q37728625	Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets?
Q36292299	Understanding melanoma stem cells
Q54525837	Understanding myeloma cancer stem cells.
Q37790294	Understanding the role of tumor stem cells in glioblastoma multiforme: a review article
Q35054645	Understanding tumor heterogeneity as functional compartments--superorganisms revisited
Q47105798	Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Q53089167	Unravelling cancer stem cell potential.
Q37303172	Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach
Q28071384	Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities
Q39389192	Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
Q38915449	Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Q41071162	Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells
Q47138911	Use of Preoperative Ependymal Enhancement on Magnetic Resonance Imaging Brain as a Marker of Grade of Glioma
Q48019517	Using Carboxy Fluorescein Succinimidyl Ester (CFSE) to Identify Quiescent Glioblastoma Stem-Like Cells
Q36968955	Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma
Q38151582	Using the molecular classification of glioblastoma to inform personalized treatment
Q50327117	Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy.
Q37102764	Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Q48246912	VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
Q58700437	VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells
Q28241300	Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor
Q34364763	Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?
Q39135169	Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival
Q28554068	Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma
Q58114002	Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation
Q48316997	Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma
Q41525538	Vascular Endothelial Growth Factor, Irradiation, and Axitinib Have Diverse Effects on Motility and Proliferation of Glioblastoma Multiforme Cells
Q37010405	Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy
Q34638979	Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells
Q90310191	Vasculogenic mimicry in carcinogenesis and clinical applications
Q39188509	Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
Q55463580	Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study.
Q37197301	Very small embryonic/epiblast-like stem cells: a missing link to support the germ line hypothesis of cancer development?
Q33665530	Virotherapy against malignant glioma stem cells
Q33516216	Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.
Q38820117	Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers
Q64065735	Visualization of spatiotemporal dynamics of human glioma stem cell invasion
Q39085353	Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway
Q55456858	WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in Glioma.
Q28552232	What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue
Q38242845	What is next in nitric oxide research? From cardiovascular system to cancer biology
Q36787343	What is the best adjuvant treatment for very young patients with medulloblastoma?
Q38081776	What is the clinical value of cancer stem cell markers in gliomas?
Q58555794	WhatsApp com between glioma stem cells and differentiated cells to sustain tumor growth
Q39750866	Whole genome expression profiling reveals a significant role for the cell junction and apoptosis pathways in breast cancer stem cells
Q93188568	Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs
Q47118235	Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
Q84892084	Will identification of a prostate cancer stem cell lead to its cure?
Q36198988	Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines
Q26746101	Wnt Signaling in Cancer Stem Cell Biology
Q98784812	Wnt activation as a therapeutic strategy in medulloblastoma
Q34232635	Wnt activation is implicated in glioblastoma radioresistance
Q44576680	Wnt and BMP signals control intestinal adenoma cell fates
Q92177011	Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells
Q39298930	Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line
Q34959673	Wnt/catenin signaling in adult stem cell physiology and disease
Q36544112	Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells
Q27023599	Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer
Q45750451	Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma
Q47161416	Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells.
Q47260163	Yin-yang balance therapy on regulating cancer stem cells.
Q61814305	ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas
Q38323022	ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Q33669366	ZEB1 regulates glioma stemness through LIF repression
Q28594320	ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state
Q92060237	ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics
Q41471985	ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.
Q57040103	Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion
Q33584755	Zebrafish as a model for cancer self-renewal
Q80716477	[Identification of the molecular bases of metastasis for the development of new therapy strategies of metastatic prostate carcinoma]
Q39411391	c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Q33385645	c-Myc is required for maintenance of glioma cancer stem cells
Q34805209	hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.
Q38099450	iNOS: a potential therapeutic target for malignant glioma
Q54985726	let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer.
Q47583443	m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells.
Q38794065	mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.
Q47231432	mTOR-Dependent Cell Proliferation in the Brain.
Q54321491	miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells.
Q38973879	miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.
Q21245271	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
Q45044001	miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.
Q39274141	miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.
Q36191985	miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Q34299316	miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling
Q33750928	miR-200b inhibits CD133+ glioma cells by targeting the AKT pathway
Q36070278	miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells
Q34311637	miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways
Q35591447	miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
Q99241288	miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs
Q38411340	miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence
Q36995222	microRNA and stem cell function
Q36225874	microRNA signature for human pancreatic cancer invasion and metastasis
Q91807615	microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Q37690899	n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma
Q37419204	p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.
Q35640069	p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation
Q39775907	p53 Regulates LIF expression in human medulloblastoma cells.
Q57498203	p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy
Q36826121	p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells
Q42034071	p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer
Q37522828	p53 isoform profiling in glioblastoma and injured brain
Q36848202	p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies
Q37609205	p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
Q37653216	p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells
Q33671652	p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells
Q34102240	s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue
Q38228596	sGC-cGMP signaling: target for anticancer therapy
Q26765364	shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy
Q90630421	shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth
Q45870855	siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth
Q36352945	uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells
Q28763621	von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells
Q33722280	β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.
Q34589698	βArrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer
Q34101839	γ-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence
Q42532937	γ-Secretase inhibitor-resistant glioblastoma stem cells require RBPJ to propagate

P6179	Dimensions Publication ID	1027226854
P356	DOI	10.1038/NATURE03128
P3181	OpenCitations bibliographic resource ID	212775
P698	PubMed publication ID	15549107
P5875	ResearchGate publication ID	8178346

P50	author	Cynthia Hawkins	Q64584929
		Michael D Cusimano	Q64597393
		Jeremy A. Squire	Q39802515
P2093	author name string	Jane Bayani
		R Mark Henkelman
		Peter B Dirks
		Sheila K Singh
		Ian D Clarke
		Takuichiro Hide
P2860	cites work	Cancerous stem cells can arise from pediatric brain tumors	Q24569653
		Prospective identification of tumorigenic breast cancer cells	Q24683474
		Stem cells, cancer, and cancer stem cells	Q27860878
		Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell	Q27861001
		A cell initiating human acute myeloid leukaemia after transplantation into SCID mice	Q28131777
		Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro	Q28219465
		Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma	Q28286168
		Direct isolation of human central nervous system stem cells	Q28318408
		CNS stem cells express a new class of intermediate filament protein	Q28577391
		Applying the principles of stem-cell biology to cancer	Q29622827
		The WHO classification of tumors of the nervous system	Q33845646
		Gliomagenesis: genetic alterations and mouse models	Q34186001
		Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?	Q34542144
		Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line	Q34544440
		Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors	Q34641731
		Breast cancer stem cells revealed	Q34913482
		Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.	Q35171149
		A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice	Q35211546
		Getting at the root and stem of brain tumors.	Q35810715
		Human trophoblast contains an intracellular protein reactive with an antibody against CD133--a novel marker for trophoblast.	Q40786267
		Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity	Q47634506
		Human brain tumor xenografts in nude mice as a chemotherapy model.	Q48801358
		Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.	Q55475226
		Epidermal growth factor receptor and Ink4a/Arf	Q57277079
P433	issue	7015
P407	language of work or name	English	Q1860
P921	main subject	brain	Q1073
P304	page(s)	396-401
P577	publication date	2004-11-18
P1433	published in	Nature	Q180445
P1476	title	Identification of human brain tumour initiating cells
P478	volume	432

Identification of human brain tumour initiating cells

scientific article (publication date: 18 November 2004)

Reverse relations